IPCS INCHEM Home


    INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY

    CONCISE INTERNATIONAL CHEMICAL ASSESSMENT DOCUMENT NO. 9


    N-PHENYL-1-NAPHTHYLAMINE

    INTER-ORGANIZATION PROGRAMME FOR THE SOUND MANAGEMENT OF CHEMICALS
    A cooperative agreement among UNEP, ILO, FAO, WHO, UNIDO, UNITAR and
    OECD

    This report contains the collective views of an international group of
    experts and does not necessarily represent the decisions or the stated
    policy of the United Nations Environment Programme, the International
    Labour Organisation, or the World Health Organization.

    First draft prepared by Dr G. Koennecker, Dr I. Mangelsdorf, and Dr A.
    Wibbertmann, Fraunhofer Institute for Toxicology and Aerosol Research,
    Hanover, Germany

    Published under the joint sponsorship of the United Nations
    Environment Programme, the International Labour Organisation, and the
    World Health Organization, and produced within the framework of the
    Inter-Organization Programme for the Sound Management of Chemicals.

    World Health Organization
    Geneva, 1998

         The International Programme on Chemical Safety (IPCS),
    established in 1980, is a joint venture of the United Nations
    Environment Programme (UNEP), the International Labour Organisation
    (ILO), and the World Health Organization (WHO).  The overall
    objectives of the IPCS are to establish the scientific basis for
    assessment of the risk to human health and the environment from
    exposure to chemicals, through international peer review processes, as
    a prerequisite for the promotion of chemical safety, and to provide
    technical assistance in strengthening national capacities for the
    sound management of chemicals.

         The Inter-Organization Programme for the Sound Management of
    Chemicals (IOMC) was established in 1995 by UNEP, ILO, the Food and
    Agriculture Organization of the United Nations, WHO, the United
    Nations Industrial Development Organization, the United Nations
    Institute for Training and Research, and the Organisation for Economic
    Co-operation and Development (Participating Organizations), following
    recommendations made by the 1992 UN Conference on Environment and
    Development to strengthen cooperation and increase coordination in the
    field of chemical safety.  The purpose of the IOMC is to promote
    coordination of the policies and activities pursued by the
    Participating Organizations, jointly or separately, to achieve the
    sound management of chemicals in relation to human health and the
    environment.

    WHO Library Cataloguing in Publication Data

     N-phenyl-1-naphthylamine.

         (Concise international chemical assessment document ; 9)

         First draft prepared by G. Koennecker, I. Mangelsdorf and 
         A. Wibbertmann.

         1.1-Naphthylamine - adverse effects   2.1-Naphthylamine -
         toxicity   3.Environmental exposure   I.Koennecker, G.  II.Series

         ISBN 92 4 153009 X               (NLM Classification: QD 305.A8)
         ISSN 1020-6167

         The World Health Organization welcomes requests for permission to
    reproduce or translate its publications, in part or in full. 
    Applications and enquiries should be addressed to the Office of
    Publications, World Health Organization, Geneva, Switzerland, which
    will be glad to provide the latest information on any changes made to
    the text, plans for new editions, and reprints and translations
    already available.

    (c) World Health Organization 1998

         Publications of the World Health Organization enjoy copyright
    protection in accordance with the provisions of Protocol 2 of the
    Universal Copyright Convention.  All rights reserved.

         The designations employed and the presentation of the material in
    this publication do not imply the expression of any opinion whatsoever
    on the part of the Secretariat of the World Health Organization
    concerning the legal status of any country, territory, city, or area
    or of its authorities, or concerning the delimitation of its frontiers
    or boundaries.

         The mention of specific companies or of certain manufacturers'
    products does not imply that they are endorsed or recommended by the
    World Health Organization in preference to others of a similar nature
    that are not mentioned.  Errors and omissions excepted, the names of
    proprietary products are distinguished by initial capital letters.

         The Federal Ministry for the Environment, Nature Conservation and
    Nuclear Safety, Germany, provided financial support for the printing
    of this publication.

    TABLE OF CONTENTS

         FOREWORD

    1. EXECUTIVE SUMMARY

    2. IDENTITY AND PHYSICAL/CHEMICAL PROPERTIES

    3. ANALYTICAL METHODS

    4. SOURCES OF HUMAN AND ENVIRONMENTAL EXPOSURE

    5. ENVIRONMENTAL TRANSPORT, DISTRIBUTION, AND TRANSFORMATION

    6. ENVIRONMENTAL LEVELS AND HUMAN EXPOSURE

         6.1. Environmental levels
         6.2. Human exposure

    7. COMPARATIVE KINETICS AND METABOLISM IN LABORATORY ANIMALS AND HUMANS

    8. EFFECTS ON LABORATORY MAMMALS AND  IN VITRO TEST SYSTEMS

         8.1. Single exposure
         8.2. Irritation and sensitization
         8.3. Short-term exposure
         8.4. Long-term exposure
              8.4.1. Subchronic exposure
              8.4.2. Chronic exposure and carcinogenicity
         8.5. Genotoxicity and related end-points
         8.6. Reproductive and developmental toxicity
         8.7. Immunological and neurological effects

    9. EFFECTS ON HUMANS

         9.1. Case reports
         9.2. Epidemiological studies

    10. EFFECTS ON OTHER ORGANISMS IN THE LABORATORY AND FIELD

         10.1. Aquatic environment
         10.2. Terrestrial environment

    11. EFFECTS EVALUATION

         11.1. Evaluation of health effects
               11.1.1. Hazard identification and dose-response assessment
               11.1.2. Criteria for setting guidance values for  N-phenyl-1-naphthylamine
               11.1.3. Sample risk characterization
         11.2. Evaluation of environmental effects

    12. PREVIOUS EVALUATIONS BY INTERNATIONAL BODIES

    13. HUMAN HEALTH PROTECTION AND EMERGENCY ACTION

         13.1. Human health hazards
         13.2. Advice to physicians
         13.3. Spillage

    14. CURRENT REGULATIONS, GUIDELINES, AND STANDARDS

         INTERNATIONAL CHEMICAL SAFETY CARD

         REFERENCES

         APPENDIX 1 - SOURCE DOCUMENT

         APPENDIX 2 - CICAD PEER REVIEW

         APPENDIX 3 - CICAD FINAL REVIEW BOARD

         RÉSUMÉ D'ORIENTATION

         RESUMEN DE ORIENTACION
    

    FOREWORD

         Concise International Chemical Assessment Documents (CICADs) are
    the latest in a family of publications from the International
    Programme on Chemical Safety (IPCS) - a cooperative programme of the
    World Health Organization (WHO), the International Labour Organisation
    (ILO), and the United Nations Environment Programme (UNEP).  CICADs
    join the Environmental Health Criteria documents (EHCs) as
    authoritative documents on the risk assessment of chemicals.

         CICADs are concise documents that provide summaries of the
    relevant scientific information concerning the potential effects of
    chemicals upon human health and/or the environment.  They are based on
    selected national or regional evaluation documents or on existing
    EHCs.  Before acceptance for publication as CICADs by IPCS, these
    documents undergo extensive peer review by internationally selected
    experts to ensure their completeness, accuracy in the way in which the
    original data are represented, and the validity of the conclusions
    drawn.

         The primary objective of CICADs is characterization of hazard and
    dose-response from exposure to a chemical.  CICADs are not a summary
    of all available data on a particular chemical; rather, they include
    only that information considered critical for characterization of the
    risk posed by the chemical.  The critical studies are, however,
    presented in sufficient detail to support the conclusions drawn.  For
    additional information, the reader should consult the identified
    source documents upon which the CICAD has been based.

         Risks to human health and the environment will vary considerably
    depending upon the type and extent of exposure.  Responsible
    authorities are strongly encouraged to characterize risk on the basis
    of locally measured or predicted exposure scenarios.  To assist the
    reader, examples of exposure estimation and risk characterization are
    provided in CICADs, whenever possible.  These examples cannot be
    considered as representing all possible exposure situations, but are
    provided as guidance only.  The reader is referred to EHC 1701 for
    advice on the derivation of health-based guidance values.

         While every effort is made to ensure that CICADs represent the
    current status of knowledge, new information is being developed
    constantly.  Unless otherwise stated, CICADs are based on a search of
    the scientific literature to the date shown in the executive summary. 
    In the event that a reader becomes aware of new information that would
    change the conclusions drawn in a CICAD, the reader is requested to
    contact the IPCS to inform it of the new information.

              

    1 International Programme on Chemical Safety (1994)  Assessing
     human health risks of chemicals: derivation of guidance values for
     health-based exposure limits. Geneva, World Health Organization
    (Environmental Health Criteria 170).

    Procedures

         The flow chart shows the procedures followed to produce a CICAD. 
    These procedures are designed to take advantage of the expertise that
    exists around the world - expertise that is required to produce the
    high-quality evaluations of toxicological, exposure, and other data
    that are necessary for assessing risks to human health and/or the
    environment.

         The first draft is based on an existing national, regional, or
    international review.  Authors of the first draft are usually, but not
    necessarily, from the institution that developed the original review. 
    A standard outline has been developed to encourage consistency in
    form.  The first draft undergoes primary review by IPCS to ensure that
    it meets the specified criteria for CICADs.

         The second stage involves international peer review by scientists
    known for their particular expertise and by scientists selected from
    an international roster compiled by IPCS through recommendations from
    IPCS national Contact Points and from IPCS Participating Institutions. 
    Adequate time is allowed for the selected experts to undertake a
    thorough review.  Authors are required to take reviewers' comments
    into account and revise their draft, if necessary.  The resulting
    second draft is submitted to a Final Review Board together with the
    reviewers' comments.

         The CICAD Final Review Board has several important functions:

    -    to ensure that each CICAD has been subjected to an appropriate
         and thorough peer review;
    -    to verify that the peer reviewers' comments have been addressed
         appropriately;
    -    to provide guidance to those responsible for the preparation of
         CICADs on how to resolve any remaining issues if, in the opinion
         of the Board, the author has not adequately addressed all
         comments of the reviewers; and
    -    to approve CICADs as international assessments.

    Board members serve in their personal capacity, not as representatives
    of any organization, government, or industry.  They are selected
    because of their expertise in human and environmental toxicology or
    because of their experience in the regulation of chemicals.  Boards
    are chosen according to the range of expertise required for a meeting
    and the need for balanced geographic representation.

         Board members, authors, reviewers, consultants, and advisers who
    participate in the preparation of a CICAD are required to declare any
    real or potential conflict of interest in relation to the subjects
    under discussion at any stage of the process.  Representatives of
    nongovernmental organizations may be invited to observe the
    proceedings of the Final Review Board.  Observers may participate in
    Board discussions only at the invitation of the Chairperson, and they
    may not participate in the final decision-making process.

    FIGURE 1

    1.  EXECUTIVE SUMMARY

         This CICAD on  N-phenyl-1-naphthylamine was based principally on
    a review prepared by the Fraunhofer Institute for Toxicology and
    Aerosol Research, Hanover, Germany, for the German Advisory Committee
    on Existing Chemicals of Environmental Relevance (BUA, 1993).  This
    review assesses the potential effects of  N-phenyl-1-naphthylamine on
    the environment and on human health.  Data identified up to 1992 were
    considered in the BUA report.  A comprehensive literature search of
    several on-line databases was conducted in 1997 to identify any
    relevant references published subsequent to those incorporated in the
    BUA report.  Information on the preparation and peer review of the
    source document is presented in Appendix 1.  Information on the peer
    review of this CICAD is presented in Appendix 2.  This CICAD was
    approved as an international assessment at a meeting of the Final
    Review Board, held in Berlin, Germany, on 26-28 November 1997. 
    Participants at the Final Review Board meeting are listed in Appendix
    3.  The International Chemical Safety Card (ICSC 1113) for
     N-phenyl-1-naphthylamine, produced by the International Programme on
    Chemical Safety (IPCS, 1993), has also been reproduced in this
    document.

          N-Phenyl-1-naphthylamine (CAS no. 90-30-2) is a lipophilic
    crystalline solid that is used as an antioxidant in various
    lubrication oils and as a protective agent and antioxidant in rubber
    and rubber mixtures for various products, including tyres.  Between
    1986 and 1990, the estimated worldwide production capacity of
     N-phenyl-1-naphthylamine was 3000 tonnes per year.  One German
    company is the sole producer of  N-phenyl-1-naphthylamine within the
    European Union. 

         Based upon its physical/chemical properties, the distribution of
     N-phenyl-1-naphthylamine in the environment, predicted on the basis
    of a Level II fugacity model, was approximately 36% to soil, 34% to
    sediment, 29% to water, and less than 1% each to air, suspended
    sediment, and biota.  Quantitative data on releases of
     N-phenyl-1-naphthylamine into the environment from production,
    processing, and use are not available.  Indirect discharges to soil
    and surface waters from the leakage of lubrication oils or leaching
    from decaying tyres and rubber products may occur; however,
    quantitative data are not available.  Although data were not
    identified,  N-phenyl-1-naphthylamine may be emitted to the
    atmosphere in exhaust gases during its production and processing and
    during the vulcanization of rubber mixtures.  The use of
     N-phenyl-1-naphthylamine-containing lubrication oils should not
    result in the introduction of this substance into the atmosphere, as
    these oils are applied in closed systems.  Overall, owing to its
    limited production capacity and the application of emission reduction
    techniques, the amount of  N-phenyl-1-naphthylamine released into the
    environment is expected to be low. 

         Laboratory studies yielded half-lives for the photochemical
    degradation of  N-phenyl-1-naphthylamine in water of 8.4 and 5.7 min. 
    Photolysis may lead to the preliminary breakdown of
     N-phenyl-1-naphthylamine under favourable environmental conditions,
    but further degradation is unlikely.  The substance is stable to
    hydrolysis under environmental conditions, and removal by
    biodegradation in water and soil is slow.  Owing to its moderate to
    high potential for sorption to organic soil constituents and its
    limited mineralization in soil,  N-phenyl-1-naphthylamine is presumed
    to have geoaccumulation potential.  The probability of infiltration
    into groundwater is low.  Based upon studies with  Daphnia and fish
    and its measured log  Kow of 4.2,  N-phenyl-1-naphthylamine is
    expected to have a moderate potential for bioaccumulation. 
    Nevertheless, secondary poisoning of higher trophic levels via the
    aquatic food-chain seems unlikely in view of the chemical's metabolism
    and extensive excretion.  The acute toxicity of
     N-phenyl-1-naphthylamine in fish and  Daphnia is high, with lowest
    reported no-observed-effect concentrations (NOECs) of 0.11 mg/litre
    (192 h) and 0.02 mg/litre (21 days), respectively.  Despite limited
    hydrolytic or biotic degradation, the bioavailability of this chemical
    in water is expected to be considerably reduced by sorption and
    photochemical degradation.

         Identified data on concentrations of  N-phenyl-1-naphthylamine
    in environmental media were limited to older studies from the USA, in
    which the chemical was detected in river water (2-7 µg/litre) and
    sediment (1-5 mg/kg) near a small speciality chemicals manufacturing
    plant.  Available data were inadequate to allow the assessment of
    human exposure or the prediction of concentrations using fugacity
    modelling. 

         Based upon studies conducted with laboratory animals,
     N-phenyl-1-naphthylamine is well absorbed and extensively excreted
    after ingestion.  Following ingestion by rats, 60% of the administered
    dose was excreted in the faeces and 35% in the urine within 72 h. 
    Several unidentified metabolites of  N-phenyl-1-naphthylamine have
    been detected in the urine of exposed rats.  On the basis of 
     in vitro studies, metabolism likely occurs primarily via
    hydroxylation.

         The acute oral toxicity of  N-phenyl-1-naphthylamine in
    laboratory animals is low.  In standard tests with rabbits,
     N-phenyl-1-naphthylamine was reported to be neither a skin irritant
    nor an eye irritant.  However, the skin sensitizing properties of
     N-phenyl-1-naphthylamine were revealed in the guinea-pig
    maximization test as well as in humans exposed to greases or rubber
    materials containing this chemical.

         Limited data indicate that the kidneys and liver are the main
    target organs following ingestion.  Adequate studies with which to
    derive putative effect levels were not identified.  The potential
    carcinogenicity of  N-phenyl-1-naphthylamine could not be fully
    evaluated, as none of the available studies was performed according to
    currently accepted standard protocols. 

          N-Phenyl-1-naphthylamine was not mutagenic in bacterial cells,
    nor were the frequencies of gene mutation (mouse lymphoma assay) or
    chromosomal aberrations  (in vitro metaphase analysis in Chinese
    hamster ovary cells or Chinese hamster lung cells) increased in these
    cell types exposed  in vitro.  A marginally positive result in a
    sister chromatid exchange assay conducted with Chinese hamster ovary
    cells in the presence of metabolic activation has been reported. 
    Unscheduled DNA synthesis was increased in exposed human lung (WI-38)
    cells; however, the effects were not clearly concentration dependent. 
     N-Phenyl-1-naphthylamine was negative in a dominant lethal test
    conducted in mice.  Based upon the available data,
     N-phenyl-1-naphthylamine does not appear to be genotoxic.  Data on
    the reproductive/developmental toxicity and on immunological or
    neurological effects of  N-phenyl-1-naphthylamine were not
    identified.

         An increased rate of cancer was observed in one epidemiological
    study of  N-phenyl-1-naphthylamine-exposed workers; however, owing to
    the small number of excess deaths and concomitant exposure to other
    substances, it is not possible to attribute this effect solely to
     N-phenyl-1-naphthylamine.  Although data are inadequate to allow a
    more detailed characterization of the potential health risks of
     N-phenyl-1-naphthylamine, dermal contact with the chemical should be
    avoided because of its sensitizing properties.

    2.  IDENTITY AND PHYSICAL/CHEMICAL PROPERTIES

          N-Phenyl-1-naphthylamine (CAS no. 90-30-2; C16H13N;
    1-anilinonaphthaline; phenyl-[naphthyl-(1)] amine;
    phenyl-alpha-naphthylamine) in its pure form crystallizes into lemon
    yellow prisms or needles (melting point 62-63°C).  The chemical is
    marketed in the form of brown to dark violet crystals or light brown
    to light violet granules.  The vapour pressure (1.06 œ 10-6 kPa) and
    the water solubility of  N-phenyl-1-naphthylamine at 20°C (3.0
    mg/litre) are quite low.  With a measured  n-octanol/water partition
    coefficient (log  Kow) of 4.2,  N-phenyl-1-naphthylamine is
    characterized as a lipophilic substance.  Additional properties are
    presented in the International Chemical Safety Card reproduced in this
    document.   N-Phenyl-1-naphthylamine decomposes upon heating or
    burning, producing irritating or toxic fumes or gases (nitrogen
    oxides).  The conversion for  N-phenyl-1-naphthylamine is 1 ppm =
    9.114 mg/m3 (at 101.3 kPa and 20°C).  The structural formula for
     N-phenyl-1-naphthylamine is:

    CHEMICAL STRUCTURE 1

         The commercial product has a typical purity of >99%.  Named
    impurities from three manufacturers are 1-naphthylamine (<100-500
    mg/kg), 2-naphthylamine (<3-50 mg/kg), aniline (<100-2500 mg/kg),
    1-naphthol (<5000 mg/kg), 1,1-dinaphthylamine (<1000 mg/kg), and
     N-phenyl-2-naphthylamine (500-<5000 mg/kg) (BUA, 1993; Union
    Carbide, 1996).

    3.  ANALYTICAL METHODS

          N-Phenyl-1-naphthylamine is quantified in environmental media
    either by high-performance liquid chromatography in combination with
    ultraviolet absorption or by gas chromatography combined with
    thermionic or mass spectrometric detection, flame ionization
    detection, or electron capture detection.  A method for the
    determination of secondary amines in air is suitable for the detection
    of  N-phenyl-1-naphthylamine.

         The following enrichment techniques are used for various types of
    samples: solid-phase adsorption (silica gel, silica gel/glass fibre)
    with liquid extraction (ethanol, acetic acid/2-propanol) for samples
    of air (NIOSH, 1984a,b); liquid/liquid extraction (acetonitrile,
    diethyl ether), stripping with helium, and solid adsorption (Tenax GC)
    or alkaline extraction (dichloromethane) for samples of water
    (Jungclaus et al., 1978; Lopez-Avila & Hites, 1980; Sikka et al.,
    1981; Rosenberg, 1983); liquid extraction (isopropanol) for sediment
    (Jungclaus et al., 1978; Lopez-Avila & Hites, 1980); and liquid
    extraction (methanol) for fish, tissue, and serum (Sikka et al.,
    1981).  Detection limits range from 0.1 to 1 µg/litre for water and
    from 50 to 100 µg/kg for sediment; detection limits for biological
    materials were not identified.

    4.  SOURCES OF HUMAN AND ENVIRONMENTAL EXPOSURE

         There are no known natural sources of  N-phenyl-1-naphthylamine. 
    Other than the information derived from the national source document,
    additional data on the production, use patterns, and release of this
    chemical were not identified. 

         Within the European Union, one German company is the sole
    producer of  N-phenyl-1-naphthylamine.  Between 1986 and 1990, the
    estimated worldwide production capacity of  N-phenyl-1-naphthylamine
    was 3000 tonnes per year.  Over the same period, estimated production
    capacities in Western Europe, the People's Republic of China, the USA,
    and Japan were approximately 1000-1500 tonnes per year, 1000 tonnes
    per year, 500 tonnes per year, and 300 tonnes per year, respectively. 
    Between 1986 and 1990, the consumption of  N-phenyl-1-naphthylamine
    in Germany was estimated to be approximately 300-450 tonnes per year,
    although its use is now declining.  Approximately 50-100 tonnes were
    covered by imports; exports amounted to approximately 750-1150 tonnes
    per year (BUA, 1993).  

          N-Phenyl-1-naphthylamine is used as an antioxidant in gear,
    hydraulic, lubrication, and bearing oils and as a protective agent and
    antioxidant in rubbers and rubber mixtures.  In Germany,
     N-phenyl-1-naphthylamine consumption is divided equally among these
    two uses.  In these products, the chemical acts as a radical scavenger
    in the auto-oxidation of polymers and mineral lubricants.  Average
    concentrations of  N-phenyl-1-naphthylamine in the final products are
    <1% w/w (BUA, 1993).  In the rubber industry, approximately 75% of
    the  N-phenyl-1-naphthylamine is used in products such as drums,
    buffers, conveyor belts, flexible tubes, gaskets, and footwear
    components.  The remaining 25% is used in tyres (sidewalls or carcass,
    but not treads) (BUA, 1993).

         In Germany,  N-phenyl-1-naphthylamine-containing distillation
    residues from production facilities (approximately 20 tonnes per
    year), like most gear and hydraulic oil, are disposed of in
    chemical/physical/biological treatment plants or hazardous waste
    incinerators (BUA, 1993).  About 30% of used tyres are disposed of in
    landfill sites, approximately 37% are used for the production of
    energy in the cement industry, an estimated 22% are recycled, and
    approximately 11% are exported (BUA, 1993).  Exhaust gases may be
    emitted during the production and processing of
     N-phenyl-1-naphthylamine and during the vulcanization of rubber
    mixtures at elevated temperatures; in Germany, however, emission
    reduction techniques are applied, and releases of
     N-phenyl-1-naphthylamine are therefore presumed to be low (<25 kg
    per year).  Data on levels of  N-phenyl-1-naphthylamine in exhaust
    gases from vulcanization processes are not available.  The use of
     N-phenyl-1-naphthylamine-containing lubrication oils should not
    result in the introduction of the substance into the atmosphere, as
    the oils are applied in closed systems (BUA, 1993). 

         Data on releases of  N-phenyl-1-naphthylamine in effluents from
    production and processing facilities were not identified.  Indirect
    discharges from leaching or the decay of tyres and other rubber
    products are to be expected in the long term; however, estimation of 
    amounts was not possible (BUA, 1993).  The release of
     N-phenyl-1-naphthylamine into the geosphere from the leakage of
    lubrication oils and discarded rubber products and tyres in landfill
    sites may occur; however, estimation of the amounts was not possible
    with the available data (BUA, 1993).  Information on the occurrence of
     N-phenyl-1-naphthylamine in plants or animals was not identified.

    5.  ENVIRONMENTAL TRANSPORT, DISTRIBUTION, AND TRANSFORMATION

         Based on its physical/chemical properties, the distribution of 
     N-phenyl-1-naphthylamine in the environment was predicted, using a
    Level II fugacity model (Mackay, 1991), to be 36.3% to soil, 33.9% to
    sediment, 28.9% to water, 0.8% to air, 0.06% to suspended sediment,
    and 0.02% to biota.  Input data for the Level II fugacity model were
    as follows: temperature, 298°K; atmospheric volume, 6 œ 109 m3; soil
    density, 1.5 g/cm3; density of biota, 1 g/cm3; carbon content of
    soil, 2%; carbon content of sediment, 4%; water depth, 1000 cm; water
    portion, 70%; soil depth, 15 cm; sediment depth, 3 cm; suspended
    sediment portion, 5 ppm; biota portion, 1 ppm; molar mass, 219 g/mol;
    water solubility, 3 mg/litre; vapour pressure, 1.06 mPa;
     n-octanol/water partition coefficient, 15 850; soil sorption
    coefficient, 6510; bioaccumulation factor, 760; half-lives (days) in
    air (0), water (365), soil (29.2), sediment (29.2), suspended sediment
    (29.2), and biota (0).  Owing to the lack of relevant data, it was not
    possible to predict the concentrations of  N-phenyl-1-naphthylamine
    in various media using a Level III fugacity model.  Based on its
    calculated Henry's law constant (7.748 œ 10-2 Pa.m3/mol; 20°C) and
    other information (Thomas, 1990), the volatility of
     N-phenyl-1-naphthylamine from aqueous solution is expected to be
    low.

         Based on its ultraviolet absorption spectrum, direct
    photochemical degradation of  N-phenyl-1-naphthylamine in air is
    expected (BUA, 1993).  Data concerning the photo-oxidative degradation
    of  N-phenyl-1-naphthylamine in air are not available.  Measured
    half-lives for the photochemical degradation of the chemical in water
    have been reported at 8.4 and 5.7 min (Sikka et al., 1981).  In this
    experiment, sealed tubes containing aqueous solutions of
     N-phenyl-1-naphthylamine at approximately 1 mg/litre (water
    unspecified but assumed to be distilled) were exposed to sunlight. 
    The experiment was conducted in May and repeated in June in Syracuse,
    NY (USA); no information was provided on light intensity.  A further
    experiment using a lamp at 300 nm (Rayonette Model RNR-400 mini
    photochemical reactor; no information provided on intensity)
    demonstrated that the photodegradation product was produced rapidly
    and was itself photostable.  Given the lack of detail in the report,
    the importance of photodegradation in the environment is difficult to
    assess.  There is also insufficient information to allow the
    photodegradation product to be fully characterized, but the authors
    suggest that it incorporates the basic phenylnaphthylamine skeleton. 
    It can therefore be concluded that photolysis may lead to preliminary
    breakdown of  N-phenyl-1-naphthylamine under favourable environmental
    conditions, but that further degradation is unlikely.  From
    experiments conducted in aqueous solution, hydrolysis of
     N-phenyl-1-naphthylamine under environmental conditions is expected
    to be of limited importance (Sikka et al., 1981).

         Two standard tests on biodegradation performed according to
    guideline 301C of the Organisation for Economic Co-operation and
    Development (OECD) (modified MITI-I test) reported no degradation of
     N-phenyl-1-naphthylamine (100 mg/litre initial concentration) within

    14 and 28 days, using non-adapted activated sludge (Bayer AG, 1990;
    CITI, 1992).  In tests with conditions favouring biodegradation,
     N-phenyl-1-naphthylamine was degraded with a half-life ranging from
    4 to 11 days (inocula: domestic sewage and lake water, respectively). 
    Additional substrates accelerated degradation (Sikka et al., 1981;
    Rosenberg, 1983).  Laboratory results indicate that
     N-phenyl-1-naphthylamine is inherently biodegradable in the aquatic
    compartment.

         Mineralization of  N-phenyl-1-naphthylamine (measured by the
    evolution of [14C]carbon dioxide) was 17% in soil and 35% in a soil
    suspension in buffered salt solution.  In contrast to the aquatic
    studies, the addition of degradable substrates reduced rather than
    accelerated degradation.  It was suggested that the organic materials
    increased sorption of the  N-phenyl-1-naphthylamine.  The reported
    lower degradation in soil may therefore reflect reduced
    bioavailability of the  N-phenyl-1-naphthylamine (Rosenberg, 1983). 
    Measured soil sorption coefficients  (Koc) are not available.  Using
    the regression equations of Kenaga (1980) and Kenaga & Goring (1980),
     Koc values of 2400 and 4600, respectively, were calculated for
     N-phenyl-1-naphthylamine.  Thus, soil sorption is predicted to be
    moderate to high.  From this expected sorption to organic soil
    constituents and its limited mineralization in soil,
     N-phenyl-1-naphthylamine is presumed to have geoaccumulation
    potential.  The probability of infiltration into groundwater is low
    (BUA, 1993).

         Considering its measured log  Kow of 4.2 (Ozeki & Tejima, 1979)
    and data from laboratory tests with  Daphnia and freshwater fish,
     N-phenyl-1-naphthylamine is classified as a substance with moderate
    bioaccumulation potential (Sikka et al., 1981; CITI, 1992).  For
     Daphnia magna, a mean bioconcentration factor (related to
    radioactivity) of 637 was calculated following exposure to
    [14C] N-phenyl-1-naphthylamine in a static test (solubilizer:
    acetone; steady state after 12 h).  About 50% of the accumulated
    radioactivity had been eliminated after 53 h in clean water (Sikka et
    al., 1981).  Bioconcentration factors ranging from 432 to 1285
    (related to radioactivity) and from 233 to 694 (related to
     N-phenyl-1-naphthylamine) were determined in a flow-through system
    (sublethal  N-phenyl-1-naphthylamine concentration) for the bluegill
    sunfish  (Lepomis macrochirus) at steady state.  Depuration was
    biphasic, with an elimination of [14C] N-phenyl-1-naphthylamine of
    >90% after 8 days; radioactivity could still be detected 32 days
    after treatment (Sikka et al., 1981).  Bioconcentration factors for
     N-phenyl-1-naphthylamine in common carp  (Cyprinus carpio), 
    measured in a flow-through system after 8 weeks, were on the same
    order of magnitude (427-2730) (CITI, 1992).  
     N-Phenyl-1-naphthylamine is metabolized by terrestrial and aquatic
    microorganisms and by fish to at least two or three unidentified
    metabolites (Sikka et al., 1981; Rosenberg, 1983). 

    6.  ENVIRONMENTAL LEVELS AND HUMAN EXPOSURE

    6.1  Environmental levels

         In older studies from the USA,  N-phenyl-1-naphthylamine was
    detected in river water (2-7 µg/litre) and sediment (1-5 mg/kg) near a
    small speciality chemicals manufacturing plant (Jungclaus et al.,
    1978; Lopez-Avila & Hites, 1980).  Additional data on levels of
     N-phenyl-1-naphthylamine in environmental media were not identified. 
    Based upon the use patterns of  N-phenyl-1-naphthylamine, the
    presence of this substance in soil and sediment in some
    source-dominated areas appears possible; however, quantitative data
    are not available.

    6.2  Human exposure

         Owing to its low vapour pressure and use patterns, the ingestion
    or inhalation of  N-phenyl-1-naphthylamine is expected to be minor. 
    Dermal contact with oils and rubber articles containing
     N-phenyl-1-naphthylamine may occur in the workplace.  Data on
    occupational exposure were not available from industries in Germany
    involved in the manufacture or use of  N-phenyl-1-naphthylamine.1 
    Dermal contact may also be a source of exposure for the general
    population, although this should be of minor importance because of the
    small quantities of  N-phenyl-1-naphthylamine produced and present in
    various products.  Data on concentrations of
     N-phenyl-1-naphthylamine in media relevant to assessing exposure of
    the general population were not identified.  Moreover, available data
    were insufficient to allow an estimation of human exposure based upon
    concentrations predicted from fugacity modelling.



              

    1 Personal communications concerning 1) BUA report on 
    N-phenyl-1-naphthylamine, Heidelberg, Berufsgenossenschaft der
    chemischen Industrie (BG Chemie), 27 August 1992; and 2) exposure data
    for N-phenyl-1-naphthylamine, Bundesanstalt für Arbeitsschutz,
    Dortmund, 1992.

    7.  COMPARATIVE KINETICS AND METABOLISM IN LABORATORY ANIMALS AND
        HUMANS

         Studies providing quantitative information on the absorption or
    distribution of  N-phenyl-1-naphthylamine in humans were not
    identified.  From the limited information available from studies
    conducted with laboratory animals, it can be concluded that
     N-phenyl-1-naphthylamine is well absorbed after ingestion and is
    readily excreted.   In vitro studies have demonstrated that the
    metabolism of  N-phenyl-1-naphthylamine occurs primarily via
    hydroxylation.

         In male Sprague-Dawley rats administered a single oral dose of
    160 mg [14C] N-phenyl-1-naphthylamine/kg body weight, the chemical
    was well absorbed, metabolized almost completely, and excreted
    primarily in the faeces.  Radioactivity was detected in plasma within
    60 min, with the maximum concentration measured after 4 h.  After
    24 h, 20% of the radioactivity was found in the gastrointestinal tract
    (including contents), 2.4% in fatty tissue, 0.4% in the liver, and
    0.1% in the kidneys.  Ninety per cent of the administered
    radioactivity was excreted within 48 h; 95% was excreted within 72 h
    (60% in the faeces and 35% in the urine).  In the ether extract of the
    urine, at least five radioactive metabolites were detected but not
    identified.  The elimination half-lives were reported as 1.68 h for
    the fast elimination and 33 h for the slow elimination (Sikka et al.,
    1981).

         In a study in which male rats were administered
     N-phenyl-1-naphthylamine orally, only small quantities of unchanged
     N-phenyl-1-naphthylamine were excreted in the faeces and urine (0.4
    and 0.01% of the applied dose, respectively).  Large amounts of
    glucuronide and sulfate conjugates, which were not identified further,
    were detected in the urine.  Small quantities of
     N-phenyl-1-naphthylamine were distributed in fatty tissue after
    single or multiple (6 day) oral administration, whereas the
    distribution of unchanged  N-phenyl-1-naphthylamine in liver,
    kidneys, spleen, heart, and lung was extremely low (Miyazaki et al.,
    1987).

         Mono- and dihydroxy-derivatives of  N-phenyl-1-naphthylamine
    have been identified in  in vitro metabolic studies conducted with
    rat liver microsomes (Sikka et al., 1981; Xuanxian & Wolff, 1992). 
    Sikka et al. (1981) suggested that the hydroxyl group in the
    mono-hydroxy derivative is in the naphthalene moiety at a
    para-position to the amino group, whereas at least one hydroxyl group
    in the dihydroxy-derivative is at the available para-position in the
    naphthyl ring.  Pretreatment of male rats with phenobarbital or
    3-methylcholanthrene increased the rate of microsomal metabolism,
    indicating that more than one P-450 enzyme is involved in the
    metabolism of  N-phenyl-1-naphthylamine (Xuanxian & Wolff, 1992).

         In studies conducted with human volunteers or laboratory animals,
    the isomer  N-phenyl-2-naphthylamine (CAS no. 135-88-6) was partially
    metabolized to the known human carcinogen 2-naphthylamine following
    ingestion or inhalation (NIOSH, 1976).  Although data concerning the
    formation of this metabolite are not available for
     N-phenyl-1-naphthylamine, it should be noted that, based on its
    chemical structure, it is unlikely that  N-phenyl-1-naphthylamine is
    metabolized to 2-naphthylamine.

    8.  EFFECTS ON LABORATORY MAMMALS AND  IN VITRO TEST SYSTEMS

         In most of the toxicity studies, information on the purity of
     N-phenyl-1-naphthylamine was not provided.  As discussed in
    section 2,  N-phenyl-1-naphthylamine with a typical purity of >99%
    contains numerous contaminants, and therefore the observed effects may
    not be solely attributable to  N-phenyl-1-naphthylamine.  Owing to
    the limited available toxicity data on  N-phenyl-1-naphthylamine,
    information on the isomer  N-phenyl-2-naphthylamine (a known
    contaminant of commercially available  N-phenyl-1-naphthylamine) has
    been included to aid in the identification of potential target organs. 
    There is limited evidence to suggest that the kidneys and liver are
    the main target organs following ingestion of
     N-phenyl-1-naphthylamine; this has also been demonstrated for the
    isomer  N-phenyl-2-naphthylamine.

    8.1  Single exposure

         The acute oral toxicity of  N-phenyl-1-naphthylamine is low. 
    Studies performed according to standard protocols yielded LD50s in
    male and female Wistar rats of >5000 mg/kg body weight (Bayer AG,
    1978a,b).  LD50s for male CFE rats and male CF-1 mice are
    >1625 mg/kg body weight (MacEwen & Vernot, 1974; Vernot et al.,
    1977) and 1231 mg/kg body weight (MacEwen & Vernot, 1974),
    respectively.  No specific signs of toxicity were reported. 

         Slight fatty degeneration in the liver of rabbits was observed 3
    months after a single subcutaneous injection of 200 mg
     N-phenyl-1-naphthylamine/kg body weight (Bayer AG, 1931).  Like
    other aromatic amines,  N-phenyl-1-naphthylamine induces the
    formation of methaemoglobin.  In mice, a slightly increased
    methaemoglobin level (4.1% versus 0.4% in controls) was noted within
    10 min of a single intraperitoneal administration; the increase was
    still detectable up to 24 h later (Nomura, 1977).  Mice are less
    sensitive than humans to methaemoglobin induction, and this small
    increase in methaemoglobin level may be of importance to human health. 
    Data on effects related to acute exposure to
     N-phenyl-1-naphthylamine via the inhalation route were not
    identified.

    8.2  Irritation and sensitization

         Three studies assessed skin irritation by
     N-phenyl-1-naphthylamine using the Draize method in rabbits.  In one
    study, no effects were observed within 72 h of application (no further
    information was reported) (MacEwen & Vernot, 1974).  In a study
    performed according to US Food and Drug Administration (FDA)
    standards,  N-phenyl-1-naphthylamine was classified as a very slight
    skin irritant (3/6 animals with intact skin and 2/6 animals with
    abraded skin showed a slight positive reaction) (van Beek, 1977).  In
    a test conducted according to OECD guideline 404,
     N-phenyl-1-naphthylamine was not considered to be a skin irritant. 
    Slight erythema and oedema reactions in 1/3 rabbits were observed 1 h

    after removal of the test substance, whereas no effects were noted
    after 24 or 72 h (Ciba-Geigy Corp., 1987b).  Studies conducted
    according to US FDA standards or OECD guideline 405 did not consider
     N-phenyl-1-naphthylamine to be an eye irritant.  The observed
    effects in some animals (slight conjunctivitis or swelling of the
    eyelid) were reversible within a maximum of 10 days (van Beek, 1977;
    Ciba-Geigy Corp., 1987a).

         In a guinea-pig maximization test (Magnusson & Kligman, 1970) and
    in a test performed according to OECD guideline 406,
     N-phenyl-1-naphthylamine was shown to be a strong sensitizer
    (positive reaction in 15/20 and 18/20 animals, respectively) (Boman et
    al., 1980; Ciba-Geigy Corp., 1987c).  In the modified Landsteiner's
    guinea-pig sensitization test (no further information available),
    which is not a standard method,  N-phenyl-1-naphthylamine did not
    exhibit sensitizing potential (MacEwen & Vernot, 1974).

    8.3  Short-term exposure

         In five female Sprague-Dawley rats (two untreated controls), no
    adverse clinical signs or effects on body weight gain were noted after
    daily oral (gavage) administration of 2000 mg
     N-phenyl-1-naphthylamine/kg body weight, 5 days per week for 2
    weeks.  Data concerning the purity of the test substance or the
    formulation administered were not provided.  Gross morphological
    observations (no histopathological examination) made at necropsy
    revealed no evidence of exposure-related effects (Mobil Oil Corp.,
    1989). 

         Older studies  (Bayer AG, 1931) performed with small numbers of
    rabbits, although inadequate to serve as a basis for the determination
    of putative effect levels, may provide some useful information on
    toxicity and target organs.  The oral administration of 200 mg
     N-phenyl-1-naphthylamine/kg body weight per day, 5 days per week for
    6 weeks, resulted in diarrhoea, proteinuria, slight irritation of the
    kidneys, and a fatty degeneration of the liver.  After the
    subcutaneous administration (42 times in 7 weeks) of 50 or 200 mg
     N-phenyl-1-naphthylamine/kg body weight per day, a fatty
    degeneration of the liver and single proliferation of connective
    tissue were noted 3 months after the cessation of exposure.  Dermal
    application of a 5% solution of  N-phenyl-1-naphthylamine to the ear
    (28 times within 5 weeks) produced slight skin erythema, proteinuria,
    and anorexia.  Death occurred 5 days after the 27th application, and
    necropsy revealed fatty degeneration of the liver (Bayer AG, 1931).

         In mice (sex and number not specified), the intraperitoneal
    administration of 219 mg  N-phenyl-1-naphthylamine/kg body weight for
    3 days resulted in increased methaemoglobin levels (1.6% versus 0.4%
    in controls) 48 h after treatment; methaemoglobin concentrations were
    not elevated after intraperitoneal administration of 109 mg/kg body
    weight for 9 days (Nomura, 1977).

    8.4  Long-term exposure

    8.4.1  Subchronic exposure

         There are no studies available concerning subchronic exposure to
     N-phenyl-1-naphthylamine.  In an oral 13-week study with the isomer
     N-phenyl-2-naphthylamine (approximately 98% pure, containing <1 mg
    2-naphthylamine/kg), relative liver weight in F344/N rats and B6C3F1
    mice increased in a dose-dependent fashion.  A chemical-related
    nephropathy was observed in rats, characterized by renal tubular
    epithelial degeneration and hyperplasia (NTP, 1988). 

    8.4.2  Chronic exposure and carcinogenicity

         Long-term toxicity or carcinogenicity studies performed according
    to currently accepted standard protocols using physiologically
    relevant routes of exposure were not identified.  The inhalation
    exposure of four rabbits (number of controls not provided, approximate
    dose 100 mg/day) for several months (no additional information
    provided) resulted in progressive anaemia, leucopenia, lymphocytosis,
    pneumonia, nephritis, nephrosis, formation of lung abscesses, fatty
    degeneration of the liver after 3-5 months, and death within 6-24
    months (Schär, 1930).  This study is characterized by the limited
    number of animals, methodological deficiencies, and insufficient
    documentation of results.

         Bladder tumours were not observed in a long-term study in which
    three dogs were orally administered 290 mg  N-phenyl-1-naphthylamine
    5 days per week for up to 3.5 years (DuPont, 1945; Gehrmann et al.,
    1948; Haskell Laboratory, 1971).  Owing to the limited number of
    animals and the examination for tumours only in the bladder, this
    study is inadequate for evaluation of the carcinogenic potential of
     N-phenyl-1-naphthylamine following oral administration.

         Wang et al. (1984) observed an increased incidence of malignant
    tumours in male ICR and TA-1 mice following repeated subcutaneous
    administration of  N-phenyl-1-naphthylamine (technical grade or pure;
    no additional data provided).  In ICR mice, there was a statistically
    significant increase  (p < 0.05) in the incidence of lung carcinoma
    (5/30 versus 0/24 in controls administered vehicle alone) after the
    administration of 16 mg technical-grade  N-phenyl-1-naphthylamine per
    animal 27 times over 9 weeks (total dose 432 mg per animal).  The
    incidence of kidney haemangiosarcomas was 1/30 and 0/24 in the exposed
    and control groups, respectively; however, the combined incidence of
    liver, kidney, and lung haemangiosarcomas was significantly  (p <
    0.05) increased in the exposed animals (5/30 versus 0/24 in unexposed
    controls).  The same dosing regimen using purified
     N-phenyl-1-naphthylamine produced a significant  (p < 0.05)
    increase in the incidence of kidney haemangiosarcomas (4/23 versus
    0/24 in controls); the numbers of animals with lung carcinoma were
    3/23 and 0/24 in the exposed and control groups, respectively.  The
    administration of 5.3 mg purified  N-phenyl-1-naphthylamine per
    animal, 27 times over 9 weeks (total dose 143 mg per animal), produced

    a significant  (p < 0.05) increase in the number of animals with
    lung carcinomas (6/25 versus 0/24 in controls).  The incidence of
    kidney haemangiosarcomas was not elevated (1/25 and 0/24 in the
    exposed and control groups, respectively); however, there was a
    significant increase  (p < 0.05) in the combined incidence of kidney
    and lung haemangiosarcomas (4/25 versus 0/24 in the controls).  All
    animals in the study were sacrificed after 10 months. 

         In TA-1 mice administered a total dose of 328 mg technical-grade
     N-phenyl-1-naphthylamine per animal subcutaneously over a period of
    12 weeks (48 mg peranimal over 3 weeks, followed by 280 mg per animal
    over 9 weeks), there was a significant increase  (p < 0.05) in the
    incidence of kidney haemangiosarcomas (7/19 compared with 0/18 in
    unexposed controls).  The incidence of renal tumours was also
    significantly  (p < 0.05) elevated in unilaterally nephrectomized
    TA-1 mice (one kidney was removed 1 week prior to treatment)
    subcutaneously administered a total dose of 328 mg of either purified
    or technical-grade  N-phenyl-1-naphthylamine per animal over a period
    of 12 weeks (48 mg per animal over 3 weeks, followed by 280 mg per
    animal over 9 weeks).  The incidence of kidney haemangiosarcomas in
    controls and the unilaterally nephrectomized animals administered
    either the pure or technical-grade material was 0/18, 12/16, and
    13/13, respectively (Wang et al., 1984).  Evaluation of this report is
    difficult owing to the number of individual experiments.  These
    studies are characterized by the use of small numbers of animals of a
    single sex, limited dose groups, the absence of data on mortality and
    morbidity, use of a non-physiologically relevant route of exposure,
    and insufficient characterization of the substance tested.

          N-Phenyl-2-naphthylamine, which had effects comparable to those
    of  N-phenyl-1-naphthylamine in the above-mentioned study by Wang et
    al. (1984), has been tested in a 2-year carcinogenicity bioassay (NTP,
    1988).  There was no evidence of carcinogenic activity in male or
    female F344/N rats administered diets containing 2500 or 5000 ppm
    (mg/kg)  N-phenyl-2-naphthylamine (estimated daily intakes of 100 and
    225 mg/kg body weight for males and 120 and 260 mg/kg body weight for
    females, respectively).  The lack of carcinogenicity in rats may be
    related to an inability to metabolize  N-phenyl-2-naphthylamine to
    the known animal and human carcinogen 2-naphthylamine (NTP, 1988). 
    There was no evidence of carcinogenic activity in male B6C3F1 mice
    administered diets containing 2500 or 5000 ppm (mg/kg)
     N-phenyl-2-naphthylamine (estimated daily intakes of 500 or
    1000 mg/kg body weight, respectively).  However, in female mice
    receiving these diets (estimated daily intakes of 450 or 900 mg/kg
    body weight, respectively), there was equivocal evidence of
    carcinogenic activity, based upon the occurrence of rare kidney
    neoplasms in two high-dose animals (one tubular cell adenoma and one
    tubular cell adenocarcinoma).  For non-neoplastic effects, the kidney
    was the principal target organ.  Mineralization, necrosis of the renal
    papilla, epithelial hyperplasia, calculi of the kidney pelvis,
    hydronephrosis, atrophy, fibrosis, and chronic focal inflammation of
    the kidney were observed in the high-dose female rats.  In male rats
    of both dose groups and in the high-dose female rats, cysts and acute

    suppurative inflammation of the kidney were also noted.  Nuclear
    enlargement of renal tubular epithelial cells and nephropathy were
    observed in the high-dose female mice (NTP, 1988). 

         In a dermal carcinogenicity study, approximately 0.75 mg
     N-phenyl-1-naphthylamine/kg body weight (dissolved in 50 µl toluene)
    was applied to the skin of 50 male C3H mice twice per week for 80
    weeks.  Data concerning the purity of the test substance or the
    formulation applied were not provided.  No adverse effects on survival
    or increased incidence of skin tumours were observed; however,
    pigmentation, fibrosis, scar formation, acanthosis, and hyperkeratosis
    were noted.  Histopathological examinations of organs other than the
    skin were not performed (Mobil Oil Corp., 1985).

    8.5  Genotoxicity and related end-points

         The results of experiments on the genotoxicity of
     N-phenyl-1-naphthylamine are summarized in Table 1. 
     N-Phenyl-1-naphthylamine was not mutagenic in bacterial tests
    conducted in the presence or absence of metabolic activation.  In
    mammalian cells, neither gene mutations (mouse lymphoma assay) nor
    chromosomal aberrations  (in vitro metaphase analysis in Chinese
    hamster ovary cells or Chinese hamster lung cells) were induced by
     N-phenyl-1-naphthylamine.  A sister chromatid exchange assay in
    Chinese hamster ovary cells was marginally positive in the presence of
    metabolic activation.  An unscheduled DNA synthesis assay with human
    lung (WI-38) cells yielded positive results, although the effects were
    not clearly concentration dependent.  A number of non-validated
    short-term tests yielded conflicting results on the transforming
    potential of  N-phenyl-1-naphthylamine (BUA, 1993).  Based upon the
    weight of evidence from  in vitro studies,  N-phenyl-1-naphthylamine
    does not appear to be genotoxic.

         No  in vivo somatic cell mutation tests were identified.  In a
    dominant lethal test, 10 male ICR mice were intraperitoneally
    administered 0,  50, 166, or 500 mg  N-phenyl-1-naphthylamine/kg body
    weight per day for 5 consecutive days followed by 2 days without
    exposure.  Each male was then caged with two virgin females 5 days per
    week, and the sequence was repeated weekly with two new females each
    week for 8 weeks.  Examination of females 14 days from the mid-week in
    which they were caged with the males yielded negative results (Brusick
    & Matheson, 1976, 1977).

    8.6  Reproductive and developmental toxicity

         Data on the reproductive and developmental toxicity of
     N-phenyl-1-naphthylamine were not identified.

    8.7  Immunological and neurological effects

         Data on immunological and neurological effects of
     N-phenyl-1-naphthylamine in laboratory animals were not identified.


        Table 1: In vitro genotoxicity studies on N-phenyl-1-naphthylamine.

                                                                                                                                             

                                                                        Resultsa (with / 
                                                                        without metabolic 
    Cell type (end-point)             Test concentration                activation)                Remarks               References
                                                                                                                                             

    Salmonella typhimurium TA98,      0.5-500 µl/plate with and         - / -                                            Brusick & Matheson, 
    TA100, TA1535, TA1537,            without metabolic activation                                                       1976, 1977
    TA1538; Escherichia coli
    WP2uvrA-
    (gene mutation)

    S. typhimurium TA98, TA100,       0.01-1000 µg/plate with and       - / -                                            Baden et al., 1978
    TA1535, TA1537; E. coli WP2       without metabolic activation
    (gene mutation)

    S. typhimurium TA97, TA98,        0.3-666 µg/plate with and         - / -                                            Zeiger et al., 1988
    TA100, TA1535, TA1537             without metabolic activation
    (gene mutation)

    S. typhimurium TA98, TA100,       0.2-1000 µg/plate with and        - / -                                            JETOC, 1996
    TA1537, TA1538                    without metabolic activation
    (gene mutation)

    E. coli WP2uvrA                   20-5000 µg/plate with and         - / -                                            JETOC, 1996
    (gene mutation)                   without metabolic activation

    S. typhimurium TA98, TA100,       Not provided                      - / -                                            Rannug et al., 1984
    TA1535, TA1537, TA1538
    (gene mutation)

    Saccharomyces cerevisiae D4       0.5-500 µl/plate with and         - / -                                            Brusick & Matheson,
    (gene mutation)                   without metabolic activation                                                       1976, 1977
                                                                                                                                             

    Table 1 (continued)

                                                                                                                                             

                                                                        Resultsa (with / 
                                                                        without metabolic 
    Cell type (end-point)             Test concentration                activation)                Remarks               References
                                                                                                                                             

    Mouse lymphoma (L5178Y)           0.005-0.1 µg/ml with              - / -                                            Brusick & Matheson, 
    cells                             metabolic activation                                                               1976, 1977
    (gene mutation)                   0.5-25 µg/ml without 
                                      metabolic activation

    Human lung (WI-38) cells          5, 10, or 50 µg/ml with           - / (+)              Weak positive response      Brusick & Matheson,
    (DNA repair [unscheduled          metabolic activation                                   at 50 µg/ml and toxic at    1976, 1977
    DNA synthesis])                   10, 50, or 100 µg/ml without                           100 µg/ml without 
                                      metabolic activation                                   metabolic activation;
                                                                                             effects not clearly 
                                                                                             concentration related

    Human lung (WI-38) cells          5, 10, or 50 µg/ml with and       (+) / (+)            Positive response at 10     Brusick & Matheson, 
    (DNA repair [unscheduled          without metabolic activation                           µg/ml with metabolic        1976, 1977
    DNA synthesis] )                                                                         activation; positive 
                                                                                             response at 5 and 50 
                                                                                             µg/ml without metabolic
                                                                                             activation; effects not
                                                                                             clearly concentration
                                                                                             related

    Chinese hamster ovary cells       0.6-19.9 µg/ml with               (+) / -              Marginally positive with    NTP, 1987; Loveday 
    (sister chromatid exchange)       metabolic activation                                   metabolic activation        et al., 1990
    1.8-18.2 µg/ml without metabolic activation

    Chinese hamster ovary cells       1.49-19.9 µg/ml with              - / -                                            NTP, 1987; Loveday 
    (chromosomal aberrations)         metabolic activation                                                               et al., 1990
                                      2.99-29.9 µg/ml without 
                                      metabolic activation
                                                                                                                                             

    Table 1 (continued)

                                                                                                                                             

                                                                        Resultsa (with / 
                                                                        without metabolic 
    Cell type (end-point)             Test concentration                activation)                Remarks               References
                                                                                                                                             

    Chinese hamster lung cells        15.6 µg/ml with                   - / -                                            Sofuni et al., 1990
    (chromosomal aberrations)         metabolic activation
                                      30 µg/ml without metabolic
                                      activation

                                                                                                                                             

    a - = negative result; (+) = weak positive result. 
    

    9.  EFFECTS ON HUMANS

    9.1  Case reports

          N-Phenyl-1-naphthylamine, mixed with oil (Bayer AG, 1931) or
    water (Haskell Laboratory, 1971), was not irritating when applied to
    the skin of volunteers (no data on concentrations available).  Skin
    eczema in workers has been attributed to repeated exposure to high
    levels of   N-phenyl-1-naphthylamine, possibly in combination with
    other substances.  Reportedly, the content of
     N-phenyl-1-naphthylamine in a special antirust oil had to be lowered
    from 2% to 0.5% because of skin problems.  Workers, who did not wear
    gloves, were exposed during the packaging of bearing rings covered
    with antirust-oil containing  N-phenyl-1-naphthylamine (Järvholm &
    Lavenius, 1981).

          N-Phenyl-1-naphthylamine was also reported to have sensitizing
    properties in humans.  Case-studies on patients with contact
    dermatitis, potentially associated with occupational exposure to
     N-phenyl-1-naphthylamine in greases or oils, have been identified. 
    The majority of these patients also had a positive reaction to other
    substances in the test series, such as mercaptobenzothiazole or
     p-phenylenediamine.  Lower incidences were reported in patients with
    past exposure to rubber materials (Blank & Miller, 1952; Schultheiss,
    1959; Nater, 1975; Te Lintum & Nater, 1979; Boman et al., 1980;
    Järvholm & Lavenius, 1981; Kantoh et al., 1985; Kalimo et al., 1989;
    Carmichael & Foulds, 1990).  Because of the chemical's incorporation
    into the polymer matrix, exposure to  N-phenyl-1-naphthylamine in
    rubber materials is assumed to be lower than exposure from greases or
    oils.

    9.2  Epidemiological studies

         An increased occurrence of cancers in a small packaging unit in a
    Swedish engineering company was reported in a cohort study (Järvholm &
    Lavenius, 1981).  Between 1954 and 1957, a special anticorrosive oil,
    which contained 0.5%  N-phenyl-1-naphthylamine in addition to other
    chemicals, had been used in this unit.  In 12 of 78 women in this unit
    (group A: 78 women/20 men), cancers were diagnosed between 1964 and
    1973 in several organs (predominantly the uterus and ovary).  The
    staff performing the actual packaging, and thus in contact with the
    oil, were mainly women.  Morbidity and mortality from cancer were 3.1-
    and 3.5-fold higher, respectively, than expected, based upon
    age-specific and sex-specific data from the Swedish Cancer Register
    (the standard cancer rates for the period 1974-1976 were estimated on
    the basis of the 1973 rate).  In the males of group A, no significant
    differences were established.  In another unit (reference group B: 25
    women/8 men) where anticorrosive oil without
     N-phenyl-1-naphthylamine had been used, morbidity and mortality from
    cancer were not elevated.  This was also true for reference group C (8
    women/23 men), from units that had been in contact with
     N-phenyl-1-naphthylamine-containing anticorrosive oil for a short
    period of time only, because they had demonstrated allergic reactions.

    The authors concluded that, apart from exposure to
     N-phenyl-1-naphthylamine, the formation of
     N-nitroso- N-phenyl-1-naphthylamine from sodium nitrite originating
    from the packaging paper used may be a possible explanation for the
    increased frequency of cancer in group A.


    10.  EFFECTS ON OTHER ORGANISMS IN THE LABORATORY AND FIELD

    10.1  Aquatic environment

         Valid results from laboratory tests with ciliates,  Daphnia, and
    fish indicate that  N-phenyl-1-naphthylamine is highly toxic to
    aquatic species.  An EC50 (48 h) of 2 mg
     N-phenyl-1-naphthylamine/litre (nominal concentration; static;
    solubilizer: acetone) was measured for the inhibition of cell
    proliferation of freshwater ciliates  (Tetrahymena pyriformis)
    (Epstein et al., 1967).  Forty-eight-hour LC50s from static and
    semi-static acute toxicity tests with young and adult  Daphnia magna
    were in the range of 0.30-0.68 mg  N-phenyl-1-naphthylamine/litre
    (nominal concentration; solubilizer: ethanol).  The lowest reported
    21-day LC50 from long-term semi-static tests was 0.06 mg/litre; the
    lowest reported NOEC was 0.02 mg/litre (nominal concentration;
    solubilizer: ethanol) (Sikka et al., 1981).

         Acute toxicity tests in semi-static (daily renewal of test
    medium) and flow-through systems yielded 96-h LC50s in the range of
    0.44-0.74 mg  N-phenyl-1-naphthylamine/litre for rainbow trout
     (Oncorhynchus mykiss) and >0.57-0.82 mg/litre for bluegill sunfish
    (solubilizers: ethanol and acetone, respectively; nominal
    concentrations); the lowest reported NOEC (192 h) was 0.11 mg/litre
    (Sikka et al., 1981).  Sublethal  N-phenyl-1-naphthylamine
    concentrations of approximately 5.2 and 5.6 mg/litre had teratogenic
    effects on embryos and larvae, respectively, of the clawed frog
     (Xenopus laevis).  Concentrations above 6.2 mg/litre were lethal
    (100% death of larvae within 24 h) for both (Greenhouse, 1976a,b). 
    During neurulation, an EC50 of 4.57 mg/litre for teratogenic effects
    was established.  For larvae, a 48-h LC50 of 2.3 mg/litre was
    determined (Greenhouse, 1977).  For larvae of the leopard frog 
     (Rana pipiens), a 48-h LC100 of 5 mg/litre was reported; no effects
    occurred after 24 h of exposure (Greenhouse, 1976b).

         Data on chronic effects of  N-phenyl-1-naphthylamine in the
    aquatic environment are not available.

    10.2  Terrestrial environment

         Data on toxic effects of  N-phenyl-1-naphthylamine on
    terrestrial microorganisms, plants, animals, and ecosystems are not
    available.

    11.  EFFECTS EVALUATION

    11.1  Evaluation of health effects

    11.1.1  Hazard identification and dose-response assessment

          N-Phenyl-1-naphthylamine is well absorbed and readily excreted
    following ingestion; accumulation in the body is not expected.  The
    acute oral toxicity of  N-phenyl-1-naphthylamine in laboratory
    animals is low.  Based on the results of tests performed according to
    OECD guidelines, the substance is not considered to be a skin or eye
    irritant.   N-Phenyl-1-naphthylamine has been observed to be a skin
    sensitizer in laboratory animals and humans.

         A no-observed-effect level could not be derived from the
    available toxicological studies.  There is limited evidence to suggest
    that the kidneys and liver are the main target organs following oral
    exposure to  N-phenyl-1-naphthylamine, a finding comparable to that
    observed for its isomer,  N-phenyl-2-naphthylamine.  As indicated
    above, useful data on the toxicity of  N-phenyl-1-naphthylamine are
    limited, and therefore additional data on its isomer,
     N-phenyl-2-naphthylamine, have been included to assist in the
    identification of potential target organs.  Available carcinogenicity
    studies on  N-phenyl-1-naphthylamine have not been performed
    according to currently accepted standard protocols, and therefore the
    potential carcinogenicity of this chemical cannot be fully evaluated. 
    However, in a 2-year carcinogenicity bioassay conducted with
     N-phenyl-2-naphthylamine in rats and mice, there was no evidence of
    carcinogenic activity in male or female rats or male mice and
    equivocal evidence of carcinogenic activity in female mice.

          N-Phenyl-1-naphthylamine was not mutagenic in bacterial test
    systems.  In tests with mammalian cells, some investigations yielded
    marginally positive or questionably positive results.  Based upon the
    available evidence,  N-phenyl-1-naphthylamine does not appear to be
    genotoxic.  It is worth noting, however, that several aromatic amines
    (the chemical class to which  N-phenyl-1-naphthylamine belongs),
    while yielding negative or weakly positive results in mutagenicity
    assays, are carcinogenic.

         An increased occurrence of cancers was observed in one limited
    epidemiological study of occupationally exposed individuals; however,
    because of the small number of excess deaths and concomitant exposure
    to other chemicals, it is not possible to attribute this finding
    solely to  N-phenyl-1-naphthylamine.  Information on the reproductive
    or developmental toxicity of  N-phenyl-1-naphthylamine was not
    available.

    11.1.2  Criteria for setting guidance values for
    N-phenyl-1-naphthylamine

         Data are inadequate to allow the derivation of a
    no-observed-effect level or the performance of a risk estimation for
    carcinogenicity.  Dermal contact with  N-phenyl-1-naphthylamine
    should be avoided because of its sensitizing properties.

    11.1.3  Sample risk characterization

         Owing to the lack of available data with which to derive a
    suitable guidance value as well as the lack of information on
    exposure, a sample quantitative risk characterization could not be
    performed.  At the workplace, there is a risk of dermal sensitization
    from exposure to greases and antirust oils containing
     N-phenyl-1-naphthylamine.  The risk from exposure to rubber
    materials may be much lower, owing to the low concentrations of
     N-phenyl-1-naphthylamine in such materials; a risk to the general
    population from exposure to products containing
     N-phenyl-1-naphthylamine cannot be excluded.  Although quantitative
    information on the leaching of  N-phenyl-1-naphthylamine from rubber
    products is not available, the extent of such leaching is expected to
    be low.  Any leached material is expected to be degraded faster than
    it is leached.  Indirect exposure of humans to
     N-phenyl-1-naphthylamine leached from rubber products into the soil
    is unlikely.

    11.2  Evaluation of environmental effects

         Overall, releases of  N-phenyl-1-naphthylamine to the
    environment from production and processing (e.g. vulcanization of
    rubber mixtures) are expected to be small in view of the chemical's
    low production.  Based upon the chemical's physical and chemical
    properties, it is predicted that soil and sediment will be affected
    indirectly by the leaching of  N-phenyl-1-naphthylamine from decaying
    tyres and rubber products; however, the amounts of
     N-phenyl-1-naphthylamine introduced into the environment via this
    route could not be quantified.  Data on the occurrence of
     N-phenyl-1-naphthylamine in environmental media were available only
    from some older studies for highly polluted river water and sediment
    samples; recent measurements on levels in water, soil, or biota were
    not identified.  Data on geoaccumulation or on the toxic effects of
     N-phenyl-1-naphthylamine on terrestrial microorganisms, plants,
    animals, and ecosystems were unavailable.

         As data on effect levels for terrestrial organisms or on current
    concentrations in environmental media were not available, a
    quantitative risk assessment for the main target compartments, water
    and soil, could not be carried out; however, some qualitative
    statements can be made.  Owing to its moderate to high potential for
    sorption to organic soil constituents and its limited mineralization
    in soil,  N-phenyl-1-naphthylamine released to this environmental
    compartment is presumed to have geoaccumulation potential.  The

    probability of its infiltration into groundwater is low.  In
    laboratory experiments, the acute toxicity of
     N-phenyl-1-naphthylamine in fish and  Daphnia was high, with lowest
    reported NOECs of 0.11 mg/litre (192 h) and 0.02 mg/litre (21 days),
    respectively.  Although considerable bioconcentration factors were
    measured in fish and  Daphnia, biomagnification and secondary
    poisoning of higher trophic levels via the aquatic food-chain seem
    unlikely in view of the metabolism and extensive excretion of
     N-phenyl-1-naphthylamine.  Biodegradation is expected to be the
    predominant route of environmental breakdown; in water, it is aided by
    the presence of other degradable substrates, but it is reduced in soil
    by sorption.  Available  N-phenyl-1-naphthylamine is likely to be
    biodegraded in both compartments with half-lives of days to weeks. 
    Photolysis may lead to initial degradation under favourable conditions
    but is not considered important in the mineralization of
     N-phenyl-1-naphthylamine.  Hydrolysis is of very limited or no
    importance in the environment.

    12.  PREVIOUS EVALUATIONS BY INTERNATIONAL BODIES

         Previous evaluations of  N-phenyl-1-naphthylamine by
    international bodies were not identified.  Information on
    international hazard classification and labelling is included in the
    International Chemical Safety Card reproduced in this document.

    13.  HUMAN HEALTH PROTECTION AND EMERGENCY ACTION

         Human health hazards, together with preventative and protective
    measures and first aid recommendations, are presented in the
    International Chemical Safety Card (ICSC 1113) reproduced in this
    document.

    13.1  Human health hazards

          N-Phenyl-1-naphthylamine has sensitizing properties. 

    13.2  Advice to physicians

         In case of intoxication, the treatment is supportive.  Some
    chemicals of this class induce methaemoglobinaemia.

    13.3  Spillage

         Because  N-phenyl-1-naphthylamine is classified as a sensitizer,
    emergency crews need to wear proper equipment to prevent contact with
    the skin. 


    14.  CURRENT REGULATIONS, GUIDELINES, AND STANDARDS

         Information on national regulations, guidelines, and standards
    can be found in the International Register of Potentially Toxic
    Chemicals (IRPTC), available from UNEP Chemicals (IRPTC), Geneva.

         The reader should be aware that regulatory decisions about
    chemicals taken in a certain country can be fully understood only in
    the framework of the legislation of that country.  The regulations and
    guidelines of all countries are subject to change and should always be
    verified with appropriate regulatory authorities before application.



        INTERNATIONAL CHEMICAL SAFETY CARD
                                                                                                                                              
    N-PHENYL-1-NAPHTHYLAMINE                                                                                                       ICSC: 1113
                                                                                                                                   24.03.1998
                                                                                                                                              
    CAS #      90-30-2
    RTECS #    QM4500000
    UN #
                                                            N-(1-Naphthyl)aniline
                                                         N-Phenyl-alpha-naphthylamine
                                                             C16H13N/C10H7NHC6H5
                                                           Molecular mass: 219.30
                                                                                                                                              
    TYPES OF HAZARD/   ACUTE HAZARDS/                         PREVENTION                              FIRST AID/FIRE FIGHTING
    EXPOSURE           SYMPTOMS
                                                                                                                                              
    FIRE               Combustible. Gives off irritating or   NO open flames.                         Powder, water spray, foam, carbon dioxide.
                       toxic fumes (or gases) in a fire.

    EXPLOSION                                                                                         In case of fire: keep drums, etc., cool by
                                                                                                      spraying with water.
                                                              electrical equipment and lighting.

    EXPOSURE                                                  AVOID ALL CONTACT!

    Inhalation         Blue lips or finger nails. Blue skin.  Local exhaust or breathing protection   Fresh air, rest.  Refer for medical 
                       Confusion. Convulsions. Dizziness.                                             attention.
                       Headache. Nausea.
                       Unconsciousness.

    Skin               MAY BE ABSORBED!                       Protective gloves.  Protective          Remove contaminated clothes.  Rinse skin
                                                              clothing.                               with plenty of water or shower.

    Eyes                                                      Face shield.                            First rinse with plenty of water for 
                                                                                                      several minutes (remove contact lenses if
                                                              protection.                             easily possible), then take to a doctor.

    Ingestion          (See Inhalation).                      Do not eat, drink, or smoke during      Rinse mouth.  Refer for medical attention.
                                                              work. Wash hands before eating.
                                                                                                                                              

    (continued)

                                                                                                                                              
    SPILLAGE DISPOSAL                                                        PACKAGING & LABELLING
                                                                                                                                              

    Sweep spilled substance into sealable containers.  Carefully collect     Symbol
    remainder, then remove to safe place.  Do NOT let this chemical enter    R: 
    the environment (extra personal protection: P2 filter respirator for     S:
    harmful particles).                                                      UN Hazard Class:
                                                                             UN Subsidiary Risks:
                                                                             UN Pack Group:

    EMERGENCY RESPONSE                                                       STORAGE
                                                                             Well closed.
                                                                                                                                              

                                                                  IMPORTANT DATA
                                                                                                                                              

    PHYSICAL STATE: APPEARANCE                                               ROUTES OF EXPOSURE:
    WHITE TO SLIGHT YELLOWISH CRYSTALS                                       The substance can be absorbed into the body by inhalation of its 
                                                                             aerosol, through the skin and by ingestion.

    CHEMICAL DANGERS:                                                        INHALATION RISK:
    The substance decomposes on burning producing toxic fumes                No indication can be given about the rate in which a harmful 
    including nitrogen oxides.                                               concentration in the air is reached on evaporation of this
                                                                             substance at 20°C.

    OCCUPATIONAL EXPOSURE LIMITS:                                            EFFECTS OF SHORT-TERM EXPOSURE:
    TLV not established.                                                     The substance may cause effects on the blood, resulting in
                                                                             formation of methaemoglobin. The effects may be delayed.
                                                                             Medical observation is indicated.

                                                                             EFFECTS OF LONG-TERM OR REPEATED EXPOSURE:
                                                                             Repeated or prolonged contact may cause skin sensitization.

                                                                                                                                              

    (continued)
                                                                                                                                              
                                                                   PHYSICAL PROPERTIES
                                                                                                                                              

    Melting point:              62-63°C
    Relative density
     (water =1):                1.2
    Solubility in water:        none 
    Octanol/water partition 
      coefficient as log Pow:   4.2
                                                                                                                                              

                                                                   ENVIRONMENTAL DATA

    The substance is very toxic to aquatic organisms.  In the food chain important to humans, bioaccumulation takes place, especially in fish.

                                                                                                                                              

                                                                          NOTES

    Depending on the degree of exposure, periodic medical examination is indicated.  Specific treatment is necessary in case of poisoning with
    this substance; the appropriate means with instructions must be available.

                                                                                                                                              
    
    REFERENCES

    Baden JM, Kelley M, Simmon VF, Rice SA, Mazze RI (1978) Fluroxene
    mutagenicity.  Mutation research, 58:183-191.

    Bayer AG (1931)  Physiologische Eigenschaften von 
     Phenyl-alpha-naphthylamin und Phenyl-œ-naphthylamin. Ludwigshafen,
    I.G. Farben (not available in print).

    Bayer AG (1978a)  Akute orale Toxizität von Additin 30 
     (Phenyl-alpha-naphthylamin) bei weiblichen Wistar Ratten. Wuppertal,
    Bayer AG (not available in print).

    Bayer AG (1978b)  Akute orale Toxizität von Additin 30 
     (Phenyl-alpha-naphthylamin) bei männlichen Wistar Ratten. Wuppertal,
    Bayer AG (not available in print).

    Bayer AG (1990)  Biologischer Abbau von Vulkanox PAN (OECD Guideline 
     301C; modifiziert). Prüfbericht vom 05.12.1990. Leverkusen, Bayer AG
    (not available in print).

    Blank IH, Miller OG (1952) A study of rubber adhesives in shoes as the
    cause of dermatitis of the feet.  Journal of the American Medical 
     Association, 149:1371-1374.

    Boman A, Hagelthorn G, Jeansson I, Karlberg A-T, Rystedt I, Wahlberg
    JE (1980) Phenyl-alpha-naphthylamine - case report and guinea pig
    studies.  Contact dermatitis, 6:299-300.

    Brusick D, Matheson DW (1976)  Mutagen and oncogen study on 
     N-phenyl-alpha-naphthylamine - final report (Litton Bionetics, Inc.,
    Kensington, MD). Wright-Patterson Air Force Base, OH, Aerospace
    Medical Research Laboratory (Report No. AMRL-TR-76-79).

    Brusick D, Matheson D (1977) Mutagenic evaluation of
    1,1-dimethylhydrazine, methylhydrazine and
     N-phenyl-alpha-naphthylamine. In:  Proceedings of the 7th annual 
     conference on environmental toxicology, 13-15 October 1976.
    Wright-Patterson Air Force Base, OH, Aerospace Medical Research
    Laboratory, pp. 108-129 (Report No. AMRL-TR-76-125).

    BUA (1993)  BUA-Stoffbericht N-phenyl-1-naphthylamin. Beratergremium
    fuer Umweltrelevante Altstoffe. Weinheim, VCH VerlagsGmbH (Report No.
    113; April 1993).

    Carmichael AJ, Foulds IS (1990) Isolated naphthylamine allergy to
    phenyl-alpha-naphthylamine.  Contact dermatitis, 22:298-299.

    Ciba-Geigy Corp. (1987a)  N-Phenyl-1-naphthylamine: Acute dermal 
     irritation/corrosion study in the rabbit (final report) - with cover
    letter dated 10/02/91. Hawthorne, NY, US Environmental Protection
    Agency, Office of Toxic Substances (EPA Report OTS 0533599; Doc.
    ID 86-920000033).

    Ciba-Geigy Corp. (1987b)  N-Phenyl-1-naphthylamine: Acute eye 
     irritation/corrosion study in the rabbit (final report) - with cover
    letter dated 10/02/91. Hawthorne, NY, US Environmental Protection
    Agency, Office of Toxic Substances (EPA Report OTS 0533600; Doc.
    ID 86-920000034).

    Ciba-Geigy Corp. (1987c)  N-Phenyl-1-naphthylamine: Skin 
     sensitization test in the guinea pig modified maximization test 
     (final report) - with cover letter dated 10/02/91. Hawthorne, NY, US
    Environmental Protection Agency, Office of Toxic Substances (EPA
    Report OTS 0533601; Doc. ID 86-920000035s).

    CITI (1992)  Biodegradation and bioaccumulation. Data of existing 
     chemicals based on the CSCL Japan. Tokyo, Japan Chemical Industry
    Ecology-Toxicology & Information Center, Chemicals Inspection &
    Testing Institute.

    DuPont (1945)  Aniline tumours of the bladder. Studies of urinary 
     bladder tumours. Wilmington, DE, E.I. DuPont de Nemours & Co., 7 pp.

    Epstein SS, Saporoschetz IB, Hutner SO (1967) Toxicity of antioxidants
    to  Tetrahymena pyriformis. Journal of protozoology, 14:238-244.

    Gehrmann GH, Foulger JH, Fleming AJ (1948) Occupational tumours of the
    bladder.  Proceedings of the 9th international congress on 
     industrial medicine (Chairperson: JM MacAlpine), Tudor Room, Caxton
    Hall, pp. 472-475.

    Greenhouse GA (1976a) The evaluation of toxic effects of chemicals in
    fresh water by using frog embryos and larvae.  Environmental 
     pollution, 11:303-315.

    Greenhouse G (1976b)  Effects of pollutants on eggs, embryos and 
     larvae of amphibian species. Wright-Patterson Air Force Base, OH,
    Aerospace Medical Research Laboratory, 24 pp. (Report No.
    AMRL-TR-76-31).

    Greenhouse GA (1977) Toxicity of  N-phenyl-alpha-naphthylamine and
    hydrazine to  Xenopus laevis embryos and larvae.  Bulletin of 
     environmental contamination and toxicology, 18:503-511.

    Haskell Laboratory (1971)  Memorandum to customers. Wilmington, DE,
    E.I. DuPont de Nemours & Co. [cited in McCormick WE (undated),
     Environmental health control for the rubber industry, Part II, p.
    634.]

    IPCS (1993)  International Chemical Safety Card - 
     N-phenyl-1-naphthylamine. Geneva, World Health Organization,
    International Programme on Chemical Safety (No. 1113).

    Järvholm B, Lavenius B (1981) A cohort study on cancer among workers
    exposed to an antirust oil.  Scandinavian journal of work, 
     environment & health, 7:179-184.

    JETOC (1996)  Mutagenicity test data of existing chemical substances 
     based on the toxicity investigation system of the industrial safety 
     and health law. Tokyo, Japan Chemical Industry Ecology-Toxicology &
    Information Center.

    Jungclaus GA, Lopez-Avila V, Hites RA (1978) Organic compounds in an
    industrial wastewater: a case study of their environmental impact.
     Environmental science and technology, 12:88-96.

    Kalimo K, Jolanki R, Estlander T, Kanerva L (1989) Contact allergy to
    antioxidants in industrial greases.  Contact dermatitis, 20:151-152.

    Kantoh H, Ishihara M, Itoh M, Hosono K, Nishimura M (1985) Allergens
    in rubber products.  HIFU (Skin research), 27:501-509 (in Japanese,
    with English summary).

    Kenaga EE (1980) Predicted bioconcentration factors and soil sorption
    coefficients of pesticides and other chemicals.  Ecotoxicology and 
     environmental safety, 4:26-38. 

    Kenaga EE, Goring CAI (1980) Relationship between water solubility,
    soil sorption, octanol-water partitioning, and concentration of
    chemicals in biota. In: Eaten JG, Parrish PR, Hendricks AC, eds.
     Aquatic toxicology. Philadelphia, PA, American Society for Testing
    and Materials, pp. 78-115 (ASTM Special Technical Publication 707).

    Lopez-Avila V, Hites RA (1980) Organic compounds in an industrial
    wastewater. Their transport into sediments.  Environmental science 
     and technology, 14:1382-1390.

    Loveday KS, Anderson BE, Resnick MA, Zeiger E (1990) Chromosome
    aberration and sister chromatid exchange tests in Chinese hamster
    ovary cells  in vitro. V: Results with 46 chemicals.  Environmental 
     and molecular mutagenesis, 16:272-303.

    MacEwen JD, Vernot EH (1974)  Toxic hazards research unit annual 
     technical report: 1974 (University of California). Wright-Patterson
    Air Force Base, OH, Aerospace Medical Research Laboratory (Report No.
    AMRL-TR-74-78).

    Mackay D (1991)  Multimedia models: the fugacity approach. Chelsea,
    MI, Lewis Publishers.

    Magnusson B, Kligman AM (1970)  Allergic contact dermatitis in the 
     guinea pig. Identification of contact allergens. Springfield, IL,
    Charles C. Thomas.

    Miyazaki K, Kawai S, Sasayama T, Iseki K, Arita T (1987) Absorption,
    metabolism and excretion of  N-phenyl-1-naphthylamine in rat.
     Yakuzaigaku, 47:17-22 (in Japanese, with English summary).

    Mobil Oil Corp. (1985)  Dermal carcinogenicity in mice - with cover
    letter dated 12/17/91. Princeton, NJ, US Environmental Protection
    Agency, Office of Toxic Substances (EPA Report OTS 0533828; Doc.
    ID 86-920000547S).

    Mobil Oil Corp. (1989)  Two-week oral toxicity study in female rats 
     (final report) - with cover letter dated 12/17/91. Princeton, NJ, US
    Environmental Protection Agency, Office of Toxic Substances (EPA
    Report OTS 0533821; Doc. ID 86-920000540S).

    Nater JP (1975) Überempfindlichkeit gegen Gummi.  Berufsdermatosen, 
    23:161-168.

    NIOSH (1976)  Metabolic precursors of a known human carcinogen, 
     beta-naphthylamine. Cincinnati, OH, US Department of Health and
    Human Services, National Institute of Occupational Safety and Health
    (Current Intelligence Bulletin 16; Publication No. 78-127).

    NIOSH (1984a)  NIOSH manual of analytical methods, 3rd ed.  Vol. 1. 
    Cincinnati, OH, US Department of Health and Human Services, National
    Institute of Occupational Safety and Health, pp. 2002-1 - 2002-6
    (Publication No. 84-100). 

    NIOSH (1984b)  NIOSH manual of analytical methods, 3rd ed.  Vol. 2. 
    Cincinnati, OH, US Department of Health and Human Services, National
    Institute of Occupational Safety and Health, pp. 5518-1 - 5518-4
    (Publication No. 84-100).

    Nomura A (1977) Studies of sulfhemoglobin formation by various drugs.
     Folia Pharmacologica Japonica, 73:793-802 (in Japanese, with English
    summary).

    NTP (1987)  National Toxicology Program, fiscal year 1987, annual 
     plan. Research Triangle Park, NC, US Department of Health and Human
    Services, National Institutes of Health, National Toxicology Program,
    p. 87.

    NTP (1988)  NTP technical report on the toxicology and 
     carcinogenesis studies of N-phenyl-2-naphthylamine (CAS no. 
     135-88-6) in F344/N rats and B6C3F1 mice (feed studies). Research
    Triangle Park, NC, US Department of Health and Human Services,
    National Institutes of Health, National Toxicology Program, 4 pp. (NTP
    TR 333).

    Ozeki S, Tejima K (1979) Drug interactions. V. Binding of basic
    compounds to bovine serum albumin by fluorescent probe technique.
     Chemical and pharmaceutical bulletin, 27:638-646.

    Rannug A, Rannug U, Ramel C (1984) Genotoxic effects of additives in
    synthetic elastomers with special consideration to the mechanism of 
    action of thiurames and dithiocarbamates. In:  Industrial hazards of 
     plastics and synthetic elastomers. New York, NY, Alan R. Liss Inc.,
    pp. 407-419.

    Rosenberg A (1983) Microbial metabolism of  N-phenyl-1-naphthylamine
    in soil, soil suspensions, and aquatic ecosystems.  Chemosphere, 
    12:1517-1523.

    Schär W (1930) Experimentelle Erzeugung von Blasentumoren. Die Wirkung
    langdauernder Inhalation von aromatischen Aminoverbindungen. 
     Deutsche Zeitschrift für Chirurgie, 226:81-97.

    Schultheiss E (1959) Gummi und Ekzem (3. Mitteilung), Kasuistik.
     Berufsdermatosen, 5:76-96.

    Sikka HC, Pack EJ, Sugatt RH, Banerjee S, Rosenberg A, Simpson BW
    (1981)  Environmental fate and effects of N -phenyl-1-naphthylamine 
     and its disposition and metabolism in the rat. Syracuse, NY,
    Syracuse Research Co., 106 pp. (Report No. AFOSR-TR-81-0703).

    Sofuni T, Matsuoka A, Sawada M, Ishidate M, Zeiger E, Shelby MD (1990)
    A comparison of chromosome aberration induction by 25 compounds tested
    by two hamster cell (CHL and CHO) systems in culture.  Mutation 
     research, 241:175-213.

    Te Lintum JCA, Nater JP (1979) Allergic contact dermatitis caused by
    rubber chemicals in dairy workers.  Dermatologica, 148:42-44.

    Thomas RG (1990) Volatilization from water. In: Lyman WJ, Reehl WF,
    Rosenblatt DH, eds.  Handbook of chemical property estimation 
     methods. Environmental behavior of organic compounds. New York, NY,
    McGraw-Hill Book Co., pp. 15-34.

    Union Carbide (1996)  Material safety data sheet from 2/22/96. Union
    Carbide Corporation, South Charleston Plant (USA), 8 pp.

    van Beek L (1977)  Primary skin and eye irritation tests with the 
     compound WTR 10 in albino rabbits. Zeist, TNO Central Institute on
    Nutrition and Food Research, 10 pp. (Report No. R 5468).

    Vernot EH, MacEwen JD, Haun CC, Kinkead ER (1977) Acute toxicity and
    skin corrosion data for some organic and inorganic compounds and
    aqueous solutions.  Toxicology and applied pharmacology, 42:417-423.

    Wang H, Wang D, Dzeng R (1984) Carcinogenicity of
     N-phenyl-1-naphthylamine and  N-phenyl-2-naphthylamine in mice.
     Cancer research, 44:3098-3100.

    Xuanxian X, Wolff T (1992) Metabolism of  N-phenyl-2-naphthylamine
    and  N-phenyl-1-naphthylamine by rat hepatic microsomes and
    hepatocytes.  Journal of environmental science, 4:74-83.

    Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K (1988)
     Salmonella mutagenicity tests: IV. Results from the testing of 300
    chemicals.  Environmental and molecular mutagenesis, 12:1-158.

    APPENDIX 1 - SOURCE DOCUMENT

     BUA-Stoffbericht N-phenyl-1-naphthylamin. Beratergremium fuer
    Umweltrelevante Altstoffe (Report No. 113; April 1993). VCH
    VerlagsGmbH, Weinheim

         For the BUA review process, the company that is in charge of
    writing the report (usually the largest producer in Germany) prepares
    a draft report using literature from an extensive literature search as
    well as internal company studies.  This draft is subject to a peer
    review during several readings of a working group consisting of
    representatives from government agencies, the scientific community,
    and industry.

         The English translation of the BUA report (BUA Report
     N-phenyl-1-naphthylamine. GDCh-Advisory Committee on Existing
    Chemicals of Environmental Relevance. VCH VerlagsGmbH, Weinheim) was
    released in 1994.

    APPENDIX 2 - CICAD PEER REVIEW

         The draft CICAD on  N-phenyl-1-naphthylamine was sent for review
    to institutions and organizations identified by IPCS after contact
    with IPCS national Contact Points and Participating Institutions, as
    well as to identified experts.  Comments were received from:

         Department of Health, London, United Kingdom

         Health and Safety Executive, Bootle, United Kingdom

         Health Canada, Ottawa, Canada

         National Chemicals Inspectorate (KEMI), Solna, Sweden

         National Institute for Working Life, Solna, Sweden

         National Institute of Occupational Health, Budapest, Hungary

         National Institute of Public Health, Oslo, Norway

         National Institute of Public Health and Environmental Protection,
         Bilthoven, The Netherlands

         United States Department of Health and Human Services (National
         Institute for Occupational Safety and Health, Cincinnati, USA;
         National Institute of Environmental Health Sciences, Research
         Triangle Park, USA)

    APPENDIX 3 - CICAD FINAL REVIEW BOARD

    Berlin, Germany, 26-28 November 1997

    Members

    Dr H. Ahlers, Education and Information Division, National Institute
    for Occupational Safety and Health, Cincinnati, OH, USA

    Mr R. Cary, Health Directorate, Health and Safety Executive, Bootle,
    United Kingdom

    Dr S. Dobson, Institute of Terrestrial Ecology, Huntingdon, United
    Kingdom

    Dr R.F. Hertel, Federal Institute for Health Protection of Consumers &
    Veterinary Medicine, Berlin, Germany  (Chairperson)

    Mr J.R. Hickman, Health Protection Branch, Health Canada, Ottawa,
    Ontario, Canada

    Dr  I. Mangelsdorf, Documentation and Assessment of Chemicals,
    Fraunhofer Institute for Toxicology and Aerosol Research, Hanover,
    Germany

    Ms M.E. Meek, Environmental Health Directorate, Health Canada, Ottawa,
    Ontario, Canada  (Rapporteur)

    Dr K. Paksy, Department of Reproductive Toxicology, National Institute
    of Occupational Health, Budapest, Hungary

    Mr V. Quarg, Ministry for the Environment, Nature Conservation &
    Nuclear Safety, Bonn, Germany

    Mr D. Renshaw, Department of Health, London, United Kingdom

    Dr J. Sekizawa, Division of Chemo-Bio Informatics, National Institute
    of Health Sciences, Tokyo, Japan

    Prof. S. Soliman, Department of Pesticide Chemistry, Alexandria
    University, Alexandria, Egypt  (Vice-Chairperson)

    Dr M. Wallen, National Chemicals Inspectorate (KEMI), Solna, Sweden

    Ms D. Willcocks, Chemical Assessment Division, Worksafe Australia,
    Camperdown, Australia

    Dr M. Williams-Johnson, Division of Toxicology, Agency for Toxic
    Substances and Disease Registry, Atlanta, GA, USA

    Dr K. Ziegler-Skylakakis, Senatskommission der Deutschen
    Forschungsgemeinschaft zuer Pruefung gesundheitsschaedlicher
    Arbeitsstoffe, GSF-Institut fuer Toxikologie, Neuherberg,
    Oberschleissheim, Germany

    Observers

    Mrs B. Dinham,1 The Pesticide Trust, London, United Kingdom

    Dr R. Ebert, KSU Ps-Toxicology, Huels AG, Marl, Germany (representing
    ECETOC, the European Centre for Ecotoxicology and Toxicology of
    Chemicals)

    Mr R. Green,1 International Federation of Chemical, Energy, Mine and
    General Workers' Unions, Brussels, Belgium

    Dr B. Hansen,1 European Chemicals Bureau, European Commission, Ispra,
    Italy

    Dr J. Heuer, Federal Institute for Health Protection of Consumers &
    Veterinary Medicine, Berlin, Germany

    Mr T. Jacob,1 DuPont, Washington, DC, USA

    Ms L. Onyon, Environment Directorate, Organisation for Economic
    Co-operation and Development, Paris, France

    Dr H.J. Weideli, Ciba Speciality Chemicals Inc., Basel, Switzerland
    (representing CEFIC, the European Chemical Industry Council)

    Secretariat

    Dr M. Baril, International Programme on Chemical Safety, World Health
    Organization, Geneva, Switzerland

    Dr R.G. Liteplo, Health Canada, Ottawa, Ontario, Canada

    Ms L. Regis, International Programme on Chemical Safety, World Health
    Organization, Geneva, Switzerland

    Mr A. Strawson, Health and Safety Executive, London, United Kingdom

    Dr P. Toft, Associate Director, International Programme on Chemical
    Safety, World Health Organization, Geneva, Switzerland



              

    1 Invited but unable to attend.

    RÉSUMÉ D'ORIENTATION

         Ce CICAD relatif à la  N-phényl-1-naphtylamine est fondé
    principalement sur une étude menée par l'Institut Fraunhofer de
    Toxicologie et de Recherche sur les Aérosols de Hanovre (Allemagne)
    pour le compte du Comité consultatif allemand sur les substances
    chimiques importantes pour l'environnement (BUA, 1993).  Cette étude
    évalue les effets potentiels de la  N-phényl-1-naphtylamine sur
    l'environnement et la santé humaine.  Le rapport du BUA s'appuie sur
    les données disponibles jusqu'en 1992.  Une recherche bibliographique
    approfondie a été menée en 1997 dans plusieurs bases de données en
    ligne pour retrouver toutes les références publiées postérieurement au
    rapport du BUA.  Les informations relatives à la préparation du
    document initial et à son examen par les pairs figurent à
    l'appendice 1.  Les renseignements concernant l'examen du CICAD par
    les pairs font l'objet de l'appendice 2.  Ce CICAD a été approuvé en
    tant qu'évaluation internationale lors d'une réunion du Comité
    d'évaluation finale qui s'est tenue à Berlin (Allemagne) du 26 au
    28 novembre 1997.  La liste des participants à cette réunion figure à
    l'appendice 3.  La fiche d'information sur la sécurité chimique de la
     N-phényl-1-naphtylamine (ICSC 1113), établie par le Programme
    international sur la Sécurité chimique (IPCS, 1993), est également
    reproduite dans le présent document.

         La  N-phényl-1-naphtylamine (CAS No 90-30-2) est un solide
    cristallin lipophile utilisé comme antioxygène dans diverses huiles de
    graissage et comme agent protecteur et antioxygène dans le caoutchouc
    et les mélanges à base de caoutchouc servant à la fabrication de
    différents produits, notamment les pneumatiques.  De 1986 à 1990, la
    capacité mondiale de production de la   N-phényl-1-naphtylamine a été
    estimée à 3000 tonnes par an.  Une entreprise allemande est la seule à
    produire cette substance dans l'Union européenne.

         Compte tenu des propriétés physico-chimiques de la
     N-phényl-1-naphtylamine, sa distribution dans l'environnement,
    prédite sur la base d'un modèle de fugacité de niveau II est
    approximativement la suivante : 36 % dans le sol, 34 % dans les
    sédiments, 29 % dans l'eau et moins de 1 % dans l'air, les sédiments
    en suspension et les biotes.  Il n'existe pas de données quantitatives
    sur les rejets de  N-phényl-1-naphtylamine dans l'environnement lors
    de sa production, de sa transformation et de son utilisation.  Des
    rejets indirects sont possibles dans le sol et les eaux de surface en
    cas de fuites d'huiles de graissage ou par suite d'un relargage lors
    de la dégradation des pneus et des articles en caoutchouc, mais on ne
    dispose pas de données quantitatives à ce sujet.  La
     N-phényl-1-naphtylamine peut être libérée dans l'atmosphère avec les
    gaz émis lors de sa production et de son traitement ou à l'occasion de
    la vulcanisation du caoutchouc, mais là encore, on ne dispose d'aucune
    donnée.  La présence de  N-phényl-1-naphtylamine dans les huiles de
    graissage ne devrait pas contribuer à sa libération dans l'atmosphère,
    car ces huiles sont utilisées en circuit fermé.  Globalement, compte

    tenu des capacités de production limitées et de l'application de
    techniques de réduction des émissions, la quantité de
     N-phényl-1-naphtylamine libérée dans l'environnement devrait être
    faible.

         Selon des études de laboratoire, la  N-phényl-1-naphtylamine
    subit une dégradation photochimique dans l'eau avec une demi-vie de
    8,4 ou 5,7 minutes.  La photolyse peut conduire à une dégradation
    préliminaire dans des conditions favorables, mais une dégradation
    ultérieure est peu probable.  Dans l'environnement, la substance
    résiste à l'hydrolyse et sa biodégradation dans l'eau et le sol se
    fait lentement.  En raison d'un potentiel de sorption modéré à élevé
    sur les constituants organiques du sol et d'une minéralisation limitée
    dans le sol, on peut supposer que la  N-phényl-1-naphtylamine
    présente un potentiel de géoaccumulation.  La probabilité
    d'infiltration dans les eaux souterraines est faible.  Les résultats
    d'études effectuées sur des daphnies et des poissons et un log  Ko/w
    de 4,2 laissent supposer que la  N-phényl-1-naphtylamine a un
    potentiel de bioaccumulation modéré.  Néanmoins, une contamination
    secondaire des niveaux trophiques supérieurs par la chaîne alimentaire
    aquatique semble peu probable compte tenu du fait que la substance est
    métabolisée et excrétée dans des proportions importantes.  La
     N-phényl-1-naphtylamine est très toxique pour les poissons et les
    daphnies, avec des concentrations sans effet observé (NOEC) de
    0,11 mg/litre (192 h) et 0,02 mg/litre (21 jours), respectivement. En
    dépit d'une dégradation hydrolytique ou biologique limitée, les
    mécanismes de sorption et de dégradation photochimique devraient
    contribuer à réduire considérablement la biodisponibilité de la
    substance dans l'eau.

         Les données connues sur les niveaux de  N-phényl-1-naphtylamine
    dans l'environnement se limitent aux résultats d'études relativement
    anciennes menées aux États-Unis d'Amérique, selon lesquelles la
    substance a été détectée dans l'eau (2-7 µg/litre) et les sédiments
    (1-5 mg/kg) des cours d'eau à proximité d'une petite usine de
    fabrication de produits chimiques.  Les données disponibles n'ont pas
    permis d'évaluer l'exposition humaine ni de prédire les concentrations
    à l'aide d'un modèle de fugacité.

         Selon des études menées sur des animaux de laboratoire, la
     N-phényl-1-naphtylamine est bien absorbée et facilement excrétée
    après ingestion.  Chez le rat, 60 % de la dose ingérée ont été
    excrétés dans les fèces et 35 % dans l'urine au cours des 72 heures
    suivantes.  Plusieurs métabolites non identifiées ont été détectées
    dans l'urine de rats exposés à la substance.  D'après des études
     in vitro, il semble que le principal mécanisme de métabolisation de
    la  N-phényl-1-naphtylamine soit l'hydroxylation.

         La toxicité aiguë par voie orale de la  N-phényl-1-naphtylamine
    chez les animaux de laboratoire est faible.  La substance a été
    soumise à des épreuves normalisées chez le lapin, qui ont montré
    qu'elle n'était irritante ni pour la peau ni pour l'oeil.  Toutefois,
    un test de maximalisation sur cobayes a révélé que la
     N-phényl-1-naphtylamine était un sensibilisant de la peau, ce qui a
    été confirmé par des épreuves pratiquées sur des personnes exposées à
    des graisses ou à des caoutchoucs contenant cette substance.

         Des données limitées montrent que les principaux organes cibles
    après ingestion sont les reins et le foie.  On n'a trouvé aucune étude
    permettant de déterminer les concentrations suivies d'un effet
    présumé.  Le potentiel cancérogène de la  N-phényl-1-naphtylamine n'a
    pu être pleinement évalué car aucune des études disponibles n'a été
    menée conformément aux normes actuellement reconnues.

         La  N-phényl-1-naphtylamine ne s'est pas révélée mutagène sur
    des cellules bactériennes et il n'y a pas eu augmentation de la
    fréquence des mutations géniques (analyse des mutations du lymphome de
    la souris) ni des aberrations chromosomiques (analyse  in vitro de la
    métaphase sur des cellules d'ovaires ou de poumons de hamsters
    chinois) dans ce type de cellules à la suite d'une exposition
     in vitro.  On a signalé un résultat faiblement positif dans une
    épreuve d'échange de chromatides soeurs sur des cellules d'ovaires de
    hamsters chinois avec activation métabolique.  Il y a eu augmentation
    de la synthèse non programmée d'ADN dans des cellules de poumon humain
    exposé (WI-38); toutefois, cet effet n'a pas semblé clairement lié à
    la concentration.  Un test de létalité dominante a donné un résultat
    négatif chez la souris.  D'après les données disponibles, la
     N-phényl-1-naphtylamine ne semble pas génotoxique.  Aucune donnée
    n'a été trouvée sur la toxicité pour la reproduction ou le
    développement ni sur les effets immunologiques ou neurologiques de la
     N-phényl-1-naphtylamine.

         Une étude épidémiologique a révélé une augmentation du taux de
    cancers chez des ouvriers exposés à la  N-phényl-1-naphtylamine;
    toutefois, cet effet n'a pu être attribué exclusivement à la
     N-phényl-1-naphtylamine en raison du petit nombre de décès
    supplémentaires et de l'exposition concomitante à d'autres substances. 
    Bien que les données disponibles soient insuffisantes pour
    caractériser exactement les risques potentiels pour la santé, il
    convient d'éviter le contact de la  N-phényl-1-naphtylamine avec la
    peau en raison de ses propriétés sensibilisantes.

    RESUMEN DE ORIENTACION

         Este CICAD relativo a la  N-fenil-1-naftilamina se basa
    fundamentalmente en un examen preparado por el Instituto Fraunhofer de
    Toxicología y de Investigación sobre los Aerosoles de Hannover,
    Alemania, para el Comité Consultivo Alemán sobre las Sustancias
    Químicas Importantes para el Medio Ambiente (BUA, 1993; versión
    inglesa: BUA, 1994).  Este estudio evalúa los efectos potenciales de
    la  N-fenil-1-naftilamina en el medio ambiente y la salud humana.  El
    informe del BUA se basa en los datos disponibles hasta 1992.  En 1997
    se realizó una investigación bibliográfica amplia de varias bases de
    datos en línea para encontrar todas las referencias publicadas con
    posterioridad al informe del BUA. La información sobre la preparación
    del documento original y su examen colegiado figura en el Apéndice 1.
    La información acerca del examen colegiado de este CICAD se presenta
    en el Apéndice 2.  Este CICAD se aprobó como evaluación internacional
    en una reunión de la Junta de Evaluación Final celebrada en Berlín
    (Alemania) los días 26-28 de noviembre de 1997.  La lista de
    participantes en esta reunión figura en el Apéndice 3.  La Ficha
    internacional de seguridad química (ICSC 1113) para la
     N-fenil-1-naftilamina, preparada por el Programa Internacional de
    Seguridad de las Sustancias Químicas (IPCS, 1993), también se
    reproduce en el presente documento.

         La  N-fenil-1-naftilamina (CAS Nº 90-30-2) es una sustancia
    cristalina lipófila utilizada como antioxidante en diversos aceites
    lubricantes y como agente protector y antioxidante en el caucho y las
    mezclas a base de caucho que se emplean en la fabricación de
    diferentes productos, en particular los neumáticos.  De 1986 a 1990,
    la capacidad estimada de producción mundial de  N-fenil-1-naftilamina
    fue de 3000 toneladas al año.  Una empresa alemana es la única
    productora de esta sustancia en la Unión Europea.

         Teniendo en cuenta las propiedades fisicoquímicas de la
     N-fenil-1-naftilamina, su distribución en el medio ambiente,
    prevista tomando como base el modelo de fugacidad de nivel II, es la
    siguiente: 36% en el suelo, 34% en los sedimentos, 29% en el agua y
    menos del 1% en el aire, los sedimentos en suspensión y la biota.  No
    existen datos cuantitativos de la liberación de
     N-fenil-1-naftilamina en el medio ambiente a partir de su
    producción, elaboración y uso.  Se pueden producir vertidos indirectos
    en el suelo y en las aguas superficiales en caso de derrames de
    aceites lubricantes o por lixiviación a partir de neumáticos o
    productos de caucho en descomposición, pero no se dispone de datos
    cuantitativos a este respecto.  La  N-fenil-1-naftilamina se puede
    liberar en la atmósfera con los gases de escape durante su producción
    y tratamiento y a partir de la vulcanización de las mezclas de caucho. 
    El uso de aceites lubricantes con  N-fenil-1-naftilamina no debería
    contribuir a su liberación en la atmósfera, puesto que estos aceites
    se aplican en sistemas cerrados.  En conjunto, teniendo en cuenta la
    capacidad de producción limitada y la aplicación de técnicas de
    reducción de las emisiones, la cantidad de  N-fenil-1-naftilamina
    liberada en el medio ambiente debería ser baja.

         Según los estudios de laboratorio, la  N-fenil-1-naftilamina
    sufre una degradación fotoquímica en el agua con una semivida de 8,4 y
    5,7 minutos.  La fotolisis puede dar lugar a una degradación
    preliminar en condiciones favorables, pero es poco probable que se
    produzca una degradación ulterior.  En el medio ambiente, la sustancia
    resiste la hidrólisis, y la eliminación por biodegradación en el agua
    y el suelo es lenta.  Habida cuenta de su potencial de sorción entre
    moderado y alto en los constituyentes orgánicos del suelo y de su
    mineralización limitada en el suelo, se supone que la
     N-fenil-1-naftilamina tiene un potencial de geoacumulación.  La
    probabilidad de infiltración en el agua fréatica es baja.  Los
    resultados de los estudios efectuados con  Daphnia y con peces y el
    log  Ko/w de 4,2 obtenido hacen suponer que la
     N-fenil-1-naftilamina tiene un potencial de bioacumulación moderado. 
    No obstante, la contaminación secundaria de los niveles tróficos
    superiores a través de la cadena alimentaria acuática parece poco
    probable, teniendo en cuenta que la sustancia se metaboliza y excreta
    en proporciones importantes.  La  N-fenil-1-naftilamina es muy tóxica
    para los peces y para  Daphnia, siendo la concentración sin efectos
    observados (NOEC) más que baja que se ha notificado de 0,11 mg/litro
    (192 h) y de 0,02 mg/litro (21 días), respectivamente.  A pesar de
    producirse una degradación hidrolítica o biológica limitada, los
    mecanismos de sorción y de degradación fotoquímica deberían contribuir
    a reducir considerablemente la disponibilidad de la sustancia en el
    agua.

         Los datos conocidos sobre los niveles de  N-fenil-1-naftilamina
    en el medio ambiente se limitan a los resultados de estudios
    relativamente antiguos realizados en los Estados Unidos, según los
    cuales la sustancia se detectó en el agua (2-7 µg/litro) y en los
    sedimentos (1-5 mg/kg) de un río cerca de una pequeña fábrica de
    productos químicos.  Los datos disponibles no permiten evaluar la
    exposición humana ni predecir las concentraciones utilizando un modelo
    de fugacidad.

         Según los estudios realizados en animales de laboratorio, la
     N-fenil-1-naftilamina se absorbe bien y se excreta en su mayor parte
    tras la ingestión.  En el caso de la rata, el 60% de la dosis
    administrada se excretó con las heces y el 35% con la orina en un
    plazo de 72 horas. En la orina de ratas expuestas a la sustancia se
    han detectado varios metabolitos no identificados.  Teniendo en cuenta
    los estudios  in vitro, parece que el mecanismo principal de
    metabolización de la  N-fenil-1-naftilamina es la hidroxilación.

         La toxicidad aguda por vía oral de la  N-fenil-1-naftilamina en
    animales de laboratorio es baja.  En pruebas normalizadas realizadas
    con conejos, se puso de manifiesto que la sustancia no era irritante
    de la piel ni de los ojos.  Sin embargo, en una prueba de maximización
    realizada con cobayas se observó que la  N-fenil-1-naftilamina tenía
    propiedades de sensibilizante cutáneo, y también en seres humanos
    expuestos a grasas o a materiales de caucho que contenían esta
    sustancia.

         Hay datos limitados que indican que los principales órganos
    destinatarios tras la ingestión son los riñones y el hígado.  No se ha
    encontrado ningún estudio adecuado que permita establecer posibles
    niveles de efectos.  No se ha podido evaluar completamente la posible
    carcinogenicidad de la  N-fenil-1-naftilamina, puesto que ninguno de
    los estudios disponibles se realizó de acuerdo con los protocolos
    normalizados aceptados actualmente.

         La  N-fenil-1-naftilamina no fue mutagénica en células
    bacterianas, ni produjo un aumento de la frecuencia de mutaciones
    génicas (análisis de las mutaciones del linfoma de ratón) ni de las
    aberraciones cromosómicas (análisis  in vitro de la metafase en
    células de los ovarios y de los pulmones de hámster chino) en este
    tipo de células tras la exposición  in vitro.  Se ha notificado un
    resultado débilmente positivo en un ensayo de intercambio de
    cromátidas hermanas en células de ovario de hámster chino con
    activación metabólica.  Se observó un aumento de síntesis no
    programada de ADN en células de pulmón humano expuestas (WI-38); sin
    embargo, estos efectos no parecían depender de la concentración.  El
    resultado de un ensayo de letalidad dominante realizado con
     N-fenil-1-naftilamina en ratones fue negativo.  Según los datos
    disponibles, esta sustancia no parece ser genotóxica.  No se han
    encontrado datos acerca de la toxicidad reproductiva y en el
    desarrollo y de los efectos inmunológicos o neurológicos de la
     N-fenil-1-naftilamina.

         En un estudio epidemiológico se observó un aumento de la
    frecuencia de cáncer en los trabajadores expuestos a la
     N-fenil-1-naftilamina; sin embargo, este efecto no se puede atribuir
    exclusivamente a la  N-fenil-1-naftilamina, debido al pequeño aumento
    en el número de fallecimientos y a la exposición concomitante a otras
    sustancias.  Aunque los datos disponibles sean inadecuados para
    caracterizar exactamente los riesgos potenciales para la salud,
    conviene evitar el contacto cutáneo con la  N-fenil-1-naftilamina,
    debido a sus propiedades sensibilizantes.
    




    See Also:
       Toxicological Abbreviations